| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | androsterone dehydrogenase (B-specific) activity | 3.49e-09 | 4 | 155 | 4 | GO:0047042 | |
| GeneOntologyMolecularFunction | ketoreductase activity | 3.49e-09 | 4 | 155 | 4 | GO:0045703 | |
| GeneOntologyMolecularFunction | chlordecone reductase activity | 3.49e-09 | 4 | 155 | 4 | GO:0047743 | |
| GeneOntologyMolecularFunction | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity | 1.74e-08 | 5 | 155 | 4 | GO:0047115 | |
| GeneOntologyMolecularFunction | 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity | 1.74e-08 | 5 | 155 | 4 | GO:0047020 | |
| GeneOntologyMolecularFunction | 17-beta-ketosteroid reductase (NADPH) activity | 1.74e-08 | 5 | 155 | 4 | GO:0072555 | |
| GeneOntologyMolecularFunction | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity | 1.74e-08 | 5 | 155 | 4 | GO:0047006 | |
| GeneOntologyMolecularFunction | lithocholic acid binding | 1.74e-08 | 5 | 155 | 4 | GO:1902121 | |
| GeneOntologyMolecularFunction | ketosteroid monooxygenase activity | 1.74e-08 | 5 | 155 | 4 | GO:0047086 | |
| GeneOntologyMolecularFunction | Delta4-3-oxosteroid 5beta-reductase activity | 1.74e-08 | 5 | 155 | 4 | GO:0047787 | |
| GeneOntologyMolecularFunction | geranylgeranyl reductase activity | 5.18e-08 | 6 | 155 | 4 | GO:0045550 | |
| GeneOntologyMolecularFunction | 17-beta-hydroxysteroid dehydrogenase (NADP+) activity | 1.20e-07 | 7 | 155 | 4 | GO:0072582 | |
| GeneOntologyMolecularFunction | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity | 2.39e-07 | 8 | 155 | 4 | GO:0047024 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase activity | 2.39e-07 | 8 | 155 | 4 | GO:0047023 | |
| GeneOntologyMolecularFunction | enone reductase activity | 2.39e-07 | 8 | 155 | 4 | GO:0035671 | |
| GeneOntologyMolecularFunction | androstan-3-alpha,17-beta-diol dehydrogenase activity | 4.27e-07 | 9 | 155 | 4 | GO:0047044 | |
| GeneOntologyMolecularFunction | NADP+ binding | 4.27e-07 | 9 | 155 | 4 | GO:0070401 | |
| GeneOntologyMolecularFunction | testosterone 17-beta-dehydrogenase (NADP+) activity | 7.07e-07 | 10 | 155 | 4 | GO:0047045 | |
| GeneOntologyMolecularFunction | bile acid binding | 7.07e-07 | 10 | 155 | 4 | GO:0032052 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 9.97e-07 | 24 | 155 | 5 | GO:0004745 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 1.52e-06 | 26 | 155 | 5 | GO:0004022 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 1.86e-06 | 27 | 155 | 5 | GO:0008106 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 3.22e-06 | 30 | 155 | 5 | GO:0018455 | |
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 3.29e-06 | 14 | 155 | 4 | GO:0004032 | |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 3.29e-06 | 14 | 155 | 4 | GO:0001758 | |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 4.49e-06 | 32 | 155 | 5 | GO:0004033 | |
| GeneOntologyMolecularFunction | actin filament binding | MYH1 MYO1H PSTPIP2 PSTPIP1 NEB MYO5C SPTBN4 XIRP2 MACF1 SCIN | 1.15e-05 | 227 | 155 | 10 | GO:0051015 |
| GeneOntologyMolecularFunction | estradiol 17-beta-dehydrogenase [NAD(P)+] activity | 1.54e-05 | 20 | 155 | 4 | GO:0004303 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 3.46e-05 | 48 | 155 | 5 | GO:0016620 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH1 ANK3 CLIP2 MYO1H NUF2 ADGRV1 PSTPIP2 PSTPIP1 NEB MEFV MYO5C SPTBN4 KIF9 KIF2B KCNC1 XIRP2 SVBP MACF1 SCIN ALDOC MYBPC1 MYBPC2 | 4.15e-05 | 1099 | 155 | 22 | GO:0008092 |
| GeneOntologyMolecularFunction | NADPH binding | 4.57e-05 | 26 | 155 | 4 | GO:0070402 | |
| GeneOntologyMolecularFunction | testosterone dehydrogenase [NAD(P)+] activity | 7.23e-05 | 11 | 155 | 3 | GO:0030283 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 7.33e-05 | 56 | 155 | 5 | GO:0016903 | |
| GeneOntologyMolecularFunction | actin binding | MYH1 MYO1H PSTPIP2 PSTPIP1 NEB MEFV MYO5C SPTBN4 XIRP2 MACF1 SCIN MYBPC1 MYBPC2 | 9.59e-05 | 479 | 155 | 13 | GO:0003779 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor | 1.02e-04 | 60 | 155 | 5 | GO:0016655 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 1.20e-04 | 33 | 155 | 4 | GO:0033764 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 1.35e-04 | 34 | 155 | 4 | GO:0016628 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity | 2.32e-04 | 39 | 155 | 4 | GO:0016229 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 2.57e-04 | 40 | 155 | 4 | GO:0016709 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 3.50e-04 | 120 | 155 | 6 | GO:0008013 | |
| GeneOntologyMolecularFunction | indanol dehydrogenase activity | 3.56e-04 | 4 | 155 | 2 | GO:0047718 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | STARD13 PPP4R1 DOCK8 FRS2 ADGRV1 SERPINA2 WNK1 ZEB2 RBCK1 ITIH5 PPP1R10 GPC3 SVBP RASGEF1B SH3BP5L HERC1 TEN1 ACAP2 PREX1 EVI5L ARAP2 SOS1 WDR48 | 6.05e-04 | 1418 | 155 | 23 | GO:0030234 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | SUPT20H ANK3 KAT6A NIPSNAP1 ZMYND8 FRS2 KMT2E WNK1 TBL1XR1 RBCK1 SPTBN4 KMT2D AP2A2 AP2B1 TRIM62 EPC1 MED12L SMARCD1 CAMTA1 SOS1 | 6.69e-04 | 1160 | 155 | 20 | GO:0030674 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H | 8.73e-04 | 95 | 155 | 5 | GO:0016651 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH1 ERCC6L TCP1 MYO1H RNF213 CHD2 FANCM ATP10D MYO5C KIF9 KIF2B SHPRH MACF1 | 1.02e-03 | 614 | 155 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors | 1.37e-03 | 62 | 155 | 4 | GO:0016627 | |
| GeneOntologyMolecularFunction | NADP binding | 1.37e-03 | 62 | 155 | 4 | GO:0050661 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 1.49e-03 | 107 | 155 | 5 | GO:0033293 | |
| GeneOntologyMolecularFunction | lipid binding | STARD13 AMPH CYP27C1 PCLO PHB2 AKR1C4 AKR1C1 AKR1C2 PITPNM1 SPTBN4 AP2A2 AKR1C3 SCIN ACAP2 PREX1 VPS13B ARAP2 | 1.76e-03 | 988 | 155 | 17 | GO:0008289 |
| GeneOntologyMolecularFunction | monooxygenase activity | 2.04e-03 | 115 | 155 | 5 | GO:0004497 | |
| GeneOntologyMolecularFunction | testosterone dehydrogenase (NAD+) activity | 2.08e-03 | 9 | 155 | 2 | GO:0047035 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.29e-03 | 118 | 155 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | ribosome binding | 2.46e-03 | 120 | 155 | 5 | GO:0043022 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 2.94e-03 | 37 | 155 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 3.14e-03 | 127 | 155 | 5 | GO:0016616 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity | 3.14e-03 | 11 | 155 | 2 | GO:0052629 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 3.17e-03 | 38 | 155 | 3 | GO:0000146 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | SUPT20H ANK3 KAT6A NIPSNAP1 ZMYND8 FRS2 KMT2E WNK1 TBL1XR1 RBCK1 SPTBN4 KMT2D AP2A2 AP2B1 TRIM62 EPC1 MED12L SMARCD1 CAMTA1 SOS1 | 4.21e-03 | 1356 | 155 | 20 | GO:0060090 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 4.48e-03 | 138 | 155 | 5 | GO:0016614 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | SUPT20H KAT6A ZMYND8 KMT2E TBL1XR1 RBCK1 KMT2D TRIM62 MED12L SMARCD1 CAMTA1 | 4.50e-03 | 562 | 155 | 11 | GO:0003712 |
| GeneOntologyMolecularFunction | structural constituent of muscle | 4.51e-03 | 43 | 155 | 3 | GO:0008307 | |
| GeneOntologyMolecularFunction | phosphatase binding | 4.62e-03 | 264 | 155 | 7 | GO:0019902 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3-phosphate phosphatase activity | 5.12e-03 | 14 | 155 | 2 | GO:0004438 | |
| GeneOntologyMolecularFunction | phosphatidylinositol monophosphate phosphatase activity | 5.88e-03 | 15 | 155 | 2 | GO:0052744 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NADP+) activity | 5.88e-03 | 15 | 155 | 2 | GO:0052650 | |
| GeneOntologyBiologicalProcess | response to jasmonic acid | 2.91e-09 | 4 | 153 | 4 | GO:0009753 | |
| GeneOntologyBiologicalProcess | progesterone catabolic process | 2.91e-09 | 4 | 153 | 4 | GO:0006709 | |
| GeneOntologyBiologicalProcess | cellular response to jasmonic acid stimulus | 2.91e-09 | 4 | 153 | 4 | GO:0071395 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone catabolic process | 2.91e-09 | 4 | 153 | 4 | GO:0008208 | |
| GeneOntologyBiologicalProcess | farnesol metabolic process | 1.45e-08 | 5 | 153 | 4 | GO:0016487 | |
| GeneOntologyBiologicalProcess | farnesol catabolic process | 1.45e-08 | 5 | 153 | 4 | GO:0016488 | |
| GeneOntologyBiologicalProcess | negative regulation of isoprenoid metabolic process | 1.45e-08 | 5 | 153 | 4 | GO:0045827 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid catabolic process | 1.45e-08 | 5 | 153 | 4 | GO:0016107 | |
| GeneOntologyBiologicalProcess | olefinic compound catabolic process | 1.45e-08 | 5 | 153 | 4 | GO:0120256 | |
| GeneOntologyBiologicalProcess | negative regulation of retinoic acid biosynthetic process | 1.45e-08 | 5 | 153 | 4 | GO:1900053 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid metabolic process | 4.32e-08 | 6 | 153 | 4 | GO:0006714 | |
| GeneOntologyBiologicalProcess | polyprenol catabolic process | 4.32e-08 | 6 | 153 | 4 | GO:0016095 | |
| GeneOntologyBiologicalProcess | response to prostaglandin D | 1.00e-07 | 7 | 153 | 4 | GO:0071798 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin D stimulus | 1.00e-07 | 7 | 153 | 4 | GO:0071799 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid biosynthetic process | 1.00e-07 | 7 | 153 | 4 | GO:1900052 | |
| GeneOntologyBiologicalProcess | daunorubicin metabolic process | 3.56e-07 | 9 | 153 | 4 | GO:0044597 | |
| GeneOntologyBiologicalProcess | multi-pass transmembrane protein insertion into ER membrane | 3.56e-07 | 9 | 153 | 4 | GO:0160063 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid receptor signaling pathway | 3.89e-07 | 21 | 153 | 5 | GO:0048385 | |
| GeneOntologyBiologicalProcess | retinal metabolic process | 3.89e-07 | 21 | 153 | 5 | GO:0042574 | |
| GeneOntologyBiologicalProcess | doxorubicin metabolic process | 5.90e-07 | 10 | 153 | 4 | GO:0044598 | |
| GeneOntologyBiologicalProcess | regulation of isoprenoid metabolic process | 5.90e-07 | 10 | 153 | 4 | GO:0019747 | |
| GeneOntologyBiologicalProcess | negative regulation of vitamin metabolic process | 5.90e-07 | 10 | 153 | 4 | GO:0046137 | |
| GeneOntologyBiologicalProcess | polyketide metabolic process | 5.90e-07 | 10 | 153 | 4 | GO:0030638 | |
| GeneOntologyBiologicalProcess | aminoglycoside antibiotic metabolic process | 5.90e-07 | 10 | 153 | 4 | GO:0030647 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 6.35e-07 | 23 | 153 | 5 | GO:0034310 | |
| GeneOntologyBiologicalProcess | regulation of testosterone biosynthetic process | 9.23e-07 | 11 | 153 | 4 | GO:2000224 | |
| GeneOntologyBiologicalProcess | terpenoid catabolic process | 9.23e-07 | 11 | 153 | 4 | GO:0016115 | |
| GeneOntologyBiologicalProcess | retinoic acid biosynthetic process | 2.75e-06 | 14 | 153 | 4 | GO:0002138 | |
| GeneOntologyBiologicalProcess | isoprenoid catabolic process | 2.75e-06 | 14 | 153 | 4 | GO:0008300 | |
| GeneOntologyBiologicalProcess | protein insertion into ER membrane | 3.06e-06 | 31 | 153 | 5 | GO:0045048 | |
| GeneOntologyBiologicalProcess | positive regulation of endothelial cell apoptotic process | 3.60e-06 | 32 | 153 | 5 | GO:2000353 | |
| GeneOntologyBiologicalProcess | diterpenoid biosynthetic process | 3.73e-06 | 15 | 153 | 4 | GO:0016102 | |
| GeneOntologyBiologicalProcess | testosterone biosynthetic process | 4.94e-06 | 16 | 153 | 4 | GO:0061370 | |
| GeneOntologyBiologicalProcess | negative regulation of hormone metabolic process | 4.94e-06 | 16 | 153 | 4 | GO:0032351 | |
| GeneOntologyBiologicalProcess | regulation of vitamin metabolic process | 8.21e-06 | 18 | 153 | 4 | GO:0030656 | |
| GeneOntologyBiologicalProcess | retinoic acid receptor signaling pathway | 8.67e-06 | 38 | 153 | 5 | GO:0048384 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 1.12e-05 | 40 | 153 | 5 | GO:0042573 | |
| GeneOntologyBiologicalProcess | negative regulation of nodal signaling pathway | 1.37e-05 | 7 | 153 | 3 | GO:1900108 | |
| GeneOntologyBiologicalProcess | primary alcohol metabolic process | 1.42e-05 | 106 | 153 | 7 | GO:0034308 | |
| GeneOntologyBiologicalProcess | cellular response to fatty acid | 1.43e-05 | 42 | 153 | 5 | GO:0071398 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 1.58e-05 | 21 | 153 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | terpenoid biosynthetic process | 1.58e-05 | 21 | 153 | 4 | GO:0016114 | |
| GeneOntologyBiologicalProcess | ketone catabolic process | 1.58e-05 | 21 | 153 | 4 | GO:0042182 | |
| GeneOntologyBiologicalProcess | parturition | 1.92e-05 | 22 | 153 | 4 | GO:0007567 | |
| GeneOntologyBiologicalProcess | glycoside metabolic process | 1.92e-05 | 22 | 153 | 4 | GO:0016137 | |
| GeneOntologyBiologicalProcess | progesterone metabolic process | 1.92e-05 | 22 | 153 | 4 | GO:0042448 | |
| GeneOntologyBiologicalProcess | tertiary alcohol metabolic process | 1.92e-05 | 22 | 153 | 4 | GO:1902644 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin stimulus | 2.31e-05 | 23 | 153 | 4 | GO:0071379 | |
| GeneOntologyBiologicalProcess | alcohol catabolic process | 2.51e-05 | 47 | 153 | 5 | GO:0046164 | |
| GeneOntologyBiologicalProcess | regulation of chromosome organization | 3.06e-05 | 266 | 153 | 10 | GO:0033044 | |
| GeneOntologyBiologicalProcess | regulation of nodal signaling pathway | 3.25e-05 | 9 | 153 | 3 | GO:1900107 | |
| GeneOntologyBiologicalProcess | protein insertion into membrane | 3.40e-05 | 50 | 153 | 5 | GO:0051205 | |
| GeneOntologyBiologicalProcess | regulation of ketone biosynthetic process | 3.83e-05 | 26 | 153 | 4 | GO:0010566 | |
| GeneOntologyBiologicalProcess | determination of left/right asymmetry in lateral mesoderm | 4.62e-05 | 10 | 153 | 3 | GO:0003140 | |
| GeneOntologyBiologicalProcess | cellular response to calcium ion | 4.96e-05 | 88 | 153 | 6 | GO:0071277 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA splicing, via spliceosome | 5.19e-05 | 28 | 153 | 4 | GO:0048025 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 5.28e-05 | 89 | 153 | 6 | GO:0001523 | |
| GeneOntologyBiologicalProcess | polyprenol metabolic process | 5.98e-05 | 29 | 153 | 4 | GO:0016093 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA processing | 5.98e-05 | 29 | 153 | 4 | GO:0050686 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 7.18e-05 | 94 | 153 | 6 | GO:0016101 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial cell apoptotic process | 8.27e-05 | 60 | 153 | 5 | GO:1904037 | |
| GeneOntologyBiologicalProcess | localization within membrane | FLOT2 ANK3 ZMYND8 SRP19 NCLN WNK1 NOMO1 SPTBN4 GPC3 AP2B1 NOMO2 VPS35 PEX16 MACF1 ACAP2 VPS13B NOMO3 | 9.25e-05 | 798 | 153 | 17 | GO:0051668 |
| GeneOntologyBiologicalProcess | negative regulation of RNA splicing | 1.01e-04 | 33 | 153 | 4 | GO:0033119 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 1.14e-04 | 34 | 153 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | olefinic compound biosynthetic process | 1.27e-04 | 35 | 153 | 4 | GO:0120255 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 1.33e-04 | 105 | 153 | 6 | GO:0006721 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to membrane | 1.39e-04 | 319 | 153 | 10 | GO:0090150 | |
| GeneOntologyBiologicalProcess | secondary metabolic process | 1.40e-04 | 67 | 153 | 5 | GO:0019748 | |
| GeneOntologyBiologicalProcess | response to prostaglandin | 1.43e-04 | 36 | 153 | 4 | GO:0034694 | |
| GeneOntologyBiologicalProcess | isoprenoid biosynthetic process | 1.43e-04 | 36 | 153 | 4 | GO:0008299 | |
| GeneOntologyBiologicalProcess | endoplasmic reticulum organization | 1.47e-04 | 107 | 153 | 6 | GO:0007029 | |
| GeneOntologyBiologicalProcess | response to fatty acid | 1.61e-04 | 69 | 153 | 5 | GO:0070542 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 2.11e-04 | 73 | 153 | 5 | GO:1901616 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell apoptotic process | 2.24e-04 | 74 | 153 | 5 | GO:2000351 | |
| GeneOntologyBiologicalProcess | protein localization to membrane | FLOT2 ANK3 ZMYND8 SRP19 NCLN WNK1 NOMO1 SPTBN4 GPC3 AP2B1 NOMO2 VPS35 PEX16 MACF1 NOMO3 | 2.47e-04 | 705 | 153 | 15 | GO:0072657 |
| GeneOntologyBiologicalProcess | endothelial cell apoptotic process | 3.05e-04 | 79 | 153 | 5 | GO:0072577 | |
| GeneOntologyBiologicalProcess | axon development | SEMA4D ANK3 B4GAT1 ENPP1 WNT7B LAMC3 ZEB2 B4GALT5 SPTBN4 SLITRK2 SVBP MACF1 CDH4 SOS1 | 3.12e-04 | 642 | 153 | 14 | GO:0061564 |
| GeneOntologyBiologicalProcess | positive regulation of establishment of T cell polarity | 3.25e-04 | 4 | 153 | 2 | GO:1903905 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone metabolic process | 3.42e-04 | 45 | 153 | 4 | GO:0008207 | |
| GeneOntologyBiologicalProcess | regulation of cellular component size | SEMA4D WNT7B PCLO CDHR5 NEB WNK1 SPTBN4 MACF1 SCIN CDH4 PREX1 | 3.47e-04 | 426 | 153 | 11 | GO:0032535 |
| GeneOntologyBiologicalProcess | lateral mesoderm development | 4.16e-04 | 20 | 153 | 3 | GO:0048368 | |
| GeneOntologyBiologicalProcess | vitamin metabolic process | 4.77e-04 | 133 | 153 | 6 | GO:0006766 | |
| GeneOntologyBiologicalProcess | negative regulation of activin receptor signaling pathway | 4.83e-04 | 21 | 153 | 3 | GO:0032926 | |
| GeneOntologyBiologicalProcess | regulation of chromosome segregation | 6.03e-04 | 139 | 153 | 6 | GO:0051983 | |
| GeneOntologyBiologicalProcess | regulation of mitotic metaphase/anaphase transition | 7.13e-04 | 95 | 153 | 5 | GO:0030071 | |
| GeneOntologyBiologicalProcess | aldehyde metabolic process | 7.13e-04 | 95 | 153 | 5 | GO:0006081 | |
| GeneOntologyBiologicalProcess | isoprenoid metabolic process | 7.26e-04 | 144 | 153 | 6 | GO:0006720 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 7.91e-04 | 202 | 153 | 7 | GO:0141193 | |
| GeneOntologyBiologicalProcess | prostaglandin metabolic process | 7.92e-04 | 56 | 153 | 4 | GO:0006693 | |
| GeneOntologyBiologicalProcess | regulation of protein monoubiquitination | 8.04e-04 | 6 | 153 | 2 | GO:1902525 | |
| GeneOntologyBiologicalProcess | regulation of establishment of T cell polarity | 8.04e-04 | 6 | 153 | 2 | GO:1903903 | |
| GeneOntologyBiologicalProcess | regulation of metaphase/anaphase transition of cell cycle | 8.21e-04 | 98 | 153 | 5 | GO:1902099 | |
| GeneOntologyBiologicalProcess | prostanoid metabolic process | 8.47e-04 | 57 | 153 | 4 | GO:0006692 | |
| GeneOntologyBiologicalProcess | ketone biosynthetic process | 8.47e-04 | 57 | 153 | 4 | GO:0042181 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of mitotic cell cycle | 8.99e-04 | 100 | 153 | 5 | GO:0007091 | |
| GeneOntologyBiologicalProcess | regulation of hormone metabolic process | 9.05e-04 | 58 | 153 | 4 | GO:0032350 | |
| GeneOntologyBiologicalProcess | nodal signaling pathway | 9.18e-04 | 26 | 153 | 3 | GO:0038092 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | KNTC1 TCP1 ZMYND8 NUF2 NEB TTK ZEB2 SPTBN4 PPP1R10 KIF9 SYNJ1 XIRP2 VPS35 XRN1 SMARCD1 PARN TEN1 SCIN ANAPC5 PREX1 EVI5L | 9.40e-04 | 1342 | 153 | 21 | GO:0033043 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | STARD13 MYO1H PCLO PSTPIP2 THSD7B PSTPIP1 NEB ZEB2 MYO5C SPTBN4 XIRP2 SCIN PREX1 MYBPC1 MYBPC2 | 9.51e-04 | 803 | 153 | 15 | GO:0030036 |
| GeneOntologyBiologicalProcess | organic hydroxy compound metabolic process | DHRS3 ENPP1 CYP27C1 AKR1C4 AKR1C1 AKR1C2 ZEB2 NUDT11 SYNJ1 CPQ VPS35 AKR1C3 ALDH1B1 | 1.00e-03 | 641 | 153 | 13 | GO:1901615 |
| GeneOntologyCellularComponent | multi-pass translocon complex | 3.56e-07 | 9 | 155 | 4 | GO:0160064 | |
| GeneOntologyCellularComponent | ER membrane insertion complex | 2.75e-06 | 14 | 155 | 4 | GO:0072379 | |
| GeneOntologyCellularComponent | actin cytoskeleton | KNTC1 MYH1 FLOT2 AMPH MYO1H PSTPIP2 PSTPIP1 MYZAP NEB MYO5C SPTBN4 KIF9 XIRP2 MACF1 SCIN | 2.61e-05 | 576 | 155 | 15 | GO:0015629 |
| MousePheno | parturition failure | 9.10e-07 | 10 | 116 | 4 | MP:0012010 | |
| MousePheno | hypermyelination | 1.42e-06 | 11 | 116 | 4 | MP:0010050 | |
| MousePheno | increased oligodendrocyte number | 3.04e-06 | 13 | 116 | 4 | MP:0010160 | |
| MousePheno | increased circulating progesterone level | 5.73e-06 | 15 | 116 | 4 | MP:0005186 | |
| MousePheno | long stride length | 5.73e-06 | 15 | 116 | 4 | MP:0010540 | |
| MousePheno | long gestation period | 5.73e-06 | 15 | 116 | 4 | MP:0002293 | |
| MousePheno | abnormal gestational length | 1.26e-05 | 18 | 116 | 4 | MP:0002292 | |
| MousePheno | abnormal ear physiology | MYH1 ENPP1 FRS2 AKR1C4 CACHD1 ADGRV1 PSTPIP2 TBL1XR1 AKR1C1 AKR1C2 PITPNM1 SPTBN4 SLITRK2 ACAN AKR1C3 BZW1 HERC1 ALDOC | 1.29e-05 | 684 | 116 | 18 | MP:0003878 |
| MousePheno | enhanced coordination | 1.46e-05 | 38 | 116 | 5 | MP:0003858 | |
| MousePheno | dysmyelination | 1.97e-05 | 20 | 116 | 4 | MP:0013438 | |
| MousePheno | abnormal auditory brainstem response | MYH1 ENPP1 FRS2 AKR1C4 CACHD1 ADGRV1 TBL1XR1 AKR1C1 AKR1C2 PITPNM1 SPTBN4 ACAN AKR1C3 BZW1 HERC1 ALDOC | 2.13e-05 | 576 | 116 | 16 | MP:0004738 |
| MousePheno | abnormal hearing electrophysiology | MYH1 ENPP1 FRS2 AKR1C4 CACHD1 ADGRV1 TBL1XR1 AKR1C1 AKR1C2 PITPNM1 SPTBN4 ACAN AKR1C3 BZW1 HERC1 ALDOC | 3.10e-05 | 594 | 116 | 16 | MP:0006335 |
| MousePheno | decreased vocalization | 3.77e-05 | 46 | 116 | 5 | MP:0020351 | |
| MousePheno | decreased oligodendrocyte number | 4.98e-05 | 25 | 116 | 4 | MP:0009808 | |
| MousePheno | abnormal hearing physiology | MYH1 ENPP1 FRS2 AKR1C4 CACHD1 ADGRV1 TBL1XR1 AKR1C1 AKR1C2 PITPNM1 SPTBN4 ACAN AKR1C3 BZW1 HERC1 ALDOC | 7.96e-05 | 643 | 116 | 16 | MP:0001963 |
| MousePheno | abnormal locomotor coordination | ANK3 ENPP1 FAM91A1 AKR1C4 CACHD1 NEB AKR1C1 AKR1C2 SPTBN4 ZNF106 KMT2D SYNJ1 ACAN VPS35 AKR1C3 HERC1 CAMTA1 | 9.86e-05 | 726 | 116 | 17 | MP:0003312 |
| MousePheno | abnormal gait | ANK3 ENPP1 FAM91A1 AKR1C4 NEB AKR1C1 AKR1C2 SPTBN4 ZNF106 KMT2D ACAN VPS35 AKR1C3 HERC1 | 1.01e-04 | 520 | 116 | 14 | MP:0001406 |
| MousePheno | prolonged diestrus | 1.04e-04 | 30 | 116 | 4 | MP:0009011 | |
| MousePheno | abnormal parturition | 1.53e-04 | 33 | 116 | 4 | MP:0002907 | |
| MousePheno | hearing/vestibular/ear phenotype | MYH1 ENPP1 FRS2 AKR1C4 CACHD1 ADGRV1 PSTPIP2 TBL1XR1 AKR1C1 AKR1C2 PITPNM1 SPTBN4 KMT2D SLITRK2 ACAN AKR1C3 BZW1 HERC1 ALDOC | 1.56e-04 | 905 | 116 | 19 | MP:0005377 |
| MousePheno | abnormal diestrus | 1.93e-04 | 35 | 116 | 4 | MP:0009010 | |
| MousePheno | prolonged estrous cycle | 2.96e-04 | 39 | 116 | 4 | MP:0009006 | |
| MousePheno | abnormal motor coordination/balance | ANK3 CLIP2 MYO1H AKR1C4 CACHD1 AKR1C1 AKR1C2 SPTBN4 ZNF106 KMT2D SLITRK2 SYNJ1 VPS35 AKR1C3 HERC1 CAMTA1 CDH4 VPS13B | 2.96e-04 | 873 | 116 | 18 | MP:0001516 |
| MousePheno | abnormal spine curvature | MYH1 ENPP1 PABPC4 CHD2 PSTPIP1 NEB ATXN1L ZNF106 ACAN MYBPC1 | 3.12e-04 | 318 | 116 | 10 | MP:0004174 |
| Domain | ALDOKETO_REDUCTASE_1 | 7.66e-07 | 10 | 148 | 4 | PS00798 | |
| Domain | ALDOKETO_REDUCTASE_2 | 7.66e-07 | 10 | 148 | 4 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 7.66e-07 | 10 | 148 | 4 | PS00063 | |
| Domain | Aldo/ket_reductase_CS | 7.66e-07 | 10 | 148 | 4 | IPR018170 | |
| Domain | Aldo/keto_reductase | 7.66e-07 | 10 | 148 | 4 | IPR020471 | |
| Domain | DUF2012 | 1.94e-06 | 4 | 148 | 3 | PF09430 | |
| Domain | DUF2012 | 1.94e-06 | 4 | 148 | 3 | IPR019008 | |
| Domain | - | 6.40e-06 | 16 | 148 | 4 | 3.20.20.100 | |
| Domain | NADP_OxRdtase_dom | 8.32e-06 | 17 | 148 | 4 | IPR023210 | |
| Domain | Aldo_ket_red | 8.32e-06 | 17 | 148 | 4 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 8.32e-06 | 17 | 148 | 4 | IPR001395 | |
| Domain | Carb-bd-like_fold | 2.65e-05 | 8 | 148 | 3 | IPR013784 | |
| Domain | Ribosomal_L26 | 6.24e-05 | 2 | 148 | 2 | PF16906 | |
| Domain | Ribosomal_L26/L24P_euk/arc | 6.24e-05 | 2 | 148 | 2 | IPR005756 | |
| Domain | CarboxyPept_regulatory_dom | 1.32e-04 | 13 | 148 | 3 | IPR014766 | |
| Domain | - | 1.32e-04 | 13 | 148 | 3 | 2.60.40.1120 | |
| Domain | Znf_FYVE_PHD | 1.72e-04 | 147 | 148 | 7 | IPR011011 | |
| Domain | Ribosomal_L24/26_CS | 1.86e-04 | 3 | 148 | 2 | IPR005825 | |
| Domain | RIBOSOMAL_L24 | 1.86e-04 | 3 | 148 | 2 | PS01108 | |
| Domain | - | PCLO KAT6A MARCHF6 ZMYND8 RNF213 KMT2E RBCK1 KMT2D MTMR4 TRIM62 SHPRH PDZRN4 | 2.46e-04 | 449 | 148 | 12 | 3.30.40.10 |
| Domain | Znf_RING/FYVE/PHD | PCLO KAT6A MARCHF6 ZMYND8 RNF213 KMT2E RBCK1 KMT2D MTMR4 TRIM62 SHPRH PDZRN4 | 3.00e-04 | 459 | 148 | 12 | IPR013083 |
| Domain | CarboxyPept-like_regulatory | 3.06e-04 | 17 | 148 | 3 | IPR008969 | |
| Domain | PRY | 3.35e-04 | 42 | 148 | 4 | PF13765 | |
| Domain | PRY | 5.62e-04 | 48 | 148 | 4 | SM00589 | |
| Domain | PRY | 5.62e-04 | 48 | 148 | 4 | IPR006574 | |
| Domain | PolyA | 6.14e-04 | 5 | 148 | 2 | SM00517 | |
| Domain | - | 6.14e-04 | 5 | 148 | 2 | 1.10.1900.10 | |
| Domain | PABP | 6.14e-04 | 5 | 148 | 2 | PF00658 | |
| Domain | PABP_1234 | 6.14e-04 | 5 | 148 | 2 | IPR006515 | |
| Domain | PABC | 6.14e-04 | 5 | 148 | 2 | PS51309 | |
| Domain | PABP_HYD | 6.14e-04 | 5 | 148 | 2 | IPR002004 | |
| Domain | SPRY | 6.40e-04 | 87 | 148 | 5 | SM00449 | |
| Domain | PHD | 7.10e-04 | 89 | 148 | 5 | SM00249 | |
| Domain | Znf_PHD | 7.86e-04 | 91 | 148 | 5 | IPR001965 | |
| Domain | SPRY | 9.10e-04 | 94 | 148 | 5 | PF00622 | |
| Domain | SPRY_dom | 9.10e-04 | 94 | 148 | 5 | IPR003877 | |
| Domain | B30.2/SPRY | 9.54e-04 | 95 | 148 | 5 | IPR001870 | |
| Domain | B302_SPRY | 9.54e-04 | 95 | 148 | 5 | PS50188 | |
| Domain | ZF_PHD_2 | 9.54e-04 | 95 | 148 | 5 | PS50016 | |
| Domain | Cadherin_C | 9.87e-04 | 25 | 148 | 3 | PF01049 | |
| Domain | Cadherin_cytoplasmic-dom | 9.87e-04 | 25 | 148 | 3 | IPR000233 | |
| Domain | ZF_PHD_1 | 1.00e-03 | 96 | 148 | 5 | PS01359 | |
| Domain | KOW | 1.28e-03 | 7 | 148 | 2 | SM00739 | |
| Domain | Catenin_binding_dom | 1.53e-03 | 29 | 148 | 3 | IPR027397 | |
| Domain | - | 1.53e-03 | 29 | 148 | 3 | 4.10.900.10 | |
| Domain | ARM-type_fold | 1.55e-03 | 339 | 148 | 9 | IPR016024 | |
| Domain | AH/BAR-dom | 1.69e-03 | 30 | 148 | 3 | IPR027267 | |
| Domain | - | 1.69e-03 | 30 | 148 | 3 | 1.20.1270.60 | |
| Domain | Coatomer/calthrin_app_sub_C | 1.69e-03 | 8 | 148 | 2 | IPR009028 | |
| Domain | ConA-like_dom | 1.83e-03 | 219 | 148 | 7 | IPR013320 | |
| Domain | SNF2_N | 2.04e-03 | 32 | 148 | 3 | IPR000330 | |
| Domain | SNF2_N | 2.04e-03 | 32 | 148 | 3 | PF00176 | |
| Domain | Alpha_adaptinC2 | 2.16e-03 | 9 | 148 | 2 | PF02883 | |
| Domain | Clathrin_a/b/g-adaptin_app_Ig | 2.16e-03 | 9 | 148 | 2 | IPR008152 | |
| Domain | Alpha_adaptinC2 | 2.16e-03 | 9 | 148 | 2 | SM00809 | |
| Domain | Butyrophylin | 2.31e-03 | 70 | 148 | 4 | IPR003879 | |
| Pathway | WP_BENZOAPYRENE_METABOLISM | 5.89e-07 | 9 | 119 | 4 | M39344 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_KEAP1_NRF2_SIGNALIG_PATHWAY | 5.89e-07 | 9 | 119 | 4 | M47817 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_BENZO_A_PYRENRE_TO_CYP_MEDIATED_METABOLISM | 1.52e-06 | 11 | 119 | 4 | M47812 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 3.25e-06 | 13 | 119 | 4 | M17842 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 3.25e-06 | 13 | 119 | 4 | MM14747 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 3.31e-06 | 28 | 119 | 5 | MM15188 | |
| Pathway | WP_GLUCOCORTICOID_BIOSYNTHESIS | 4.53e-06 | 14 | 119 | 4 | M46449 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 4.53e-06 | 14 | 119 | 4 | M27074 | |
| Pathway | WP_MINERALOCORTICOID_BIOSYNTHESIS | 4.53e-06 | 14 | 119 | 4 | M46453 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 4.53e-06 | 14 | 119 | 4 | MM14748 | |
| Pathway | REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX | 6.13e-06 | 15 | 119 | 4 | MM14870 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 3.67e-05 | 45 | 119 | 5 | MM15344 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 3.78e-05 | 23 | 119 | 4 | M1926 | |
| Pathway | REACTOME_PREDNISONE_ADME | 3.78e-05 | 23 | 119 | 4 | MM16639 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 3.78e-05 | 23 | 119 | 4 | MM14741 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 5.58e-05 | 49 | 119 | 5 | MM15186 | |
| Pathway | REACTOME_BUTYROPHILIN_BTN_FAMILY_INTERACTIONS | 1.22e-04 | 12 | 119 | 3 | M27738 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 1.26e-04 | 92 | 119 | 6 | MM14881 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 1.63e-04 | 33 | 119 | 4 | M5967 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 1.63e-04 | 33 | 119 | 4 | MM14737 | |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 3.49e-04 | 40 | 119 | 4 | MM15060 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 5.05e-04 | 44 | 119 | 4 | M499 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 5.51e-04 | 45 | 119 | 4 | MM14751 | |
| Pathway | REACTOME_CELL_CELL_JUNCTION_ORGANIZATION | 7.05e-04 | 48 | 119 | 4 | MM15069 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 7.05e-04 | 48 | 119 | 4 | M27642 | |
| Pubmed | 4.00e-10 | 4 | 157 | 4 | 20124700 | ||
| Pubmed | Structure and activity of the murine type 5 17beta-hydroxysteroid dehydrogenase gene(1). | 4.00e-10 | 4 | 157 | 4 | 10500239 | |
| Pubmed | Enzymatic properties of a member (AKR1C20) of the aldo-keto reductase family. | 4.00e-10 | 4 | 157 | 4 | 16508162 | |
| Pubmed | 4.00e-10 | 4 | 157 | 4 | 19487289 | ||
| Pubmed | Cloning and chromosomal localization of mouse 20alpha-hydroxysteroid dehydrogenase gene. | 4.00e-10 | 4 | 157 | 4 | 14967952 | |
| Pubmed | 4.00e-10 | 4 | 157 | 4 | 10393440 | ||
| Pubmed | Localization of 20alpha-hydroxysteroid dehydrogenase mRNA in mouse brain by in situ hybridization. | 4.00e-10 | 4 | 157 | 4 | 15193432 | |
| Pubmed | Mouse Akr1cl gene product is a prostaglandin D2 11-ketoreductase with strict substrate specificity. | 4.00e-10 | 4 | 157 | 4 | 31479646 | |
| Pubmed | 4.00e-10 | 4 | 157 | 4 | 15222881 | ||
| Pubmed | 4.00e-10 | 4 | 157 | 4 | 16191478 | ||
| Pubmed | 4.00e-10 | 4 | 157 | 4 | 15577209 | ||
| Pubmed | 4.00e-10 | 4 | 157 | 4 | 10702227 | ||
| Pubmed | 4.00e-10 | 4 | 157 | 4 | 17034817 | ||
| Pubmed | 4.00e-10 | 4 | 157 | 4 | 17629694 | ||
| Pubmed | RECON-Dependent Inflammation in Hepatocytes Enhances Listeria monocytogenes Cell-to-Cell Spread. | 4.00e-10 | 4 | 157 | 4 | 29764944 | |
| Pubmed | 4.00e-10 | 4 | 157 | 4 | 10526179 | ||
| Pubmed | 4.00e-10 | 4 | 157 | 4 | 17888864 | ||
| Pubmed | 4.00e-10 | 4 | 157 | 4 | 17442338 | ||
| Pubmed | 4.00e-10 | 4 | 157 | 4 | 28329705 | ||
| Pubmed | 4.00e-10 | 4 | 157 | 4 | 16018803 | ||
| Pubmed | 4.00e-10 | 4 | 157 | 4 | 17272929 | ||
| Pubmed | 4.00e-10 | 4 | 157 | 4 | 19237748 | ||
| Pubmed | Involvement of 20alpha-hydroxysteroid dehydrogenase in the maintenance of pregnancy in mice. | 4.00e-10 | 4 | 157 | 4 | 18667791 | |
| Pubmed | 4.00e-10 | 4 | 157 | 4 | 28259989 | ||
| Pubmed | 4.00e-10 | 4 | 157 | 4 | 21521174 | ||
| Pubmed | 4.00e-10 | 4 | 157 | 4 | 8274401 | ||
| Pubmed | 4.00e-10 | 4 | 157 | 4 | 16511129 | ||
| Pubmed | 4.00e-10 | 4 | 157 | 4 | 10803568 | ||
| Pubmed | AKR1C1 alleviates LPS‑induced ALI in mice by activating the JAK2/STAT3 signaling pathway. | 4.00e-10 | 4 | 157 | 4 | 34590152 | |
| Pubmed | 4.00e-10 | 4 | 157 | 4 | 7789999 | ||
| Pubmed | PPP4R1 SEMA4D SUPT20H ANK3 B4GAT1 CLIP2 PEG3 ZMYND8 CACHD1 HUNK WDR26 ZEB2 RBCK1 SPTBN4 THOP1 TMEM168 AP2B1 SYNJ1 NOMO2 AKR1C3 MACF1 PREX1 TARBP1 SOS1 KPNA3 | 7.79e-10 | 1285 | 157 | 25 | 35914814 | |
| Pubmed | STARD13 ANK3 DOCK8 PABPC4 ZMYND8 ZEB2 NOMO1 PPP1R10 ZNF106 KMT2D MTMR4 AP2A2 TRIM62 VPS35 MACF1 HERC1 NOMO3 | 1.78e-09 | 591 | 157 | 17 | 15231748 | |
| Pubmed | 1.99e-09 | 5 | 157 | 4 | 7737980 | ||
| Pubmed | Retinaldehyde is a substrate for human aldo-keto reductases of the 1C subfamily. | 1.99e-09 | 5 | 157 | 4 | 21851338 | |
| Pubmed | 1.99e-09 | 5 | 157 | 4 | 17872381 | ||
| Pubmed | Mouse 3alpha-hydroxysteroid dehydrogenase mRNA: a marker of lung maturity. | 1.99e-09 | 5 | 157 | 4 | 17064890 | |
| Pubmed | 1.99e-09 | 5 | 157 | 4 | 10672042 | ||
| Pubmed | 1.99e-09 | 5 | 157 | 4 | 38788959 | ||
| Pubmed | Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. | 1.99e-09 | 5 | 157 | 4 | 16984997 | |
| Pubmed | 1.99e-09 | 5 | 157 | 4 | 18003893 | ||
| Pubmed | FLOT2 VRK2 TCP1 ENPP1 PABPC4 NIPSNAP1 LAMC3 NCLN WNK1 TTK NDUFS1 COL18A1 ZNF106 MTMR4 THOP1 AP2B1 NOMO2 RPL26L1 GOLIM4 MACF1 PARN BZW1 SRRM2 KPNA3 | 4.69e-09 | 1297 | 157 | 24 | 33545068 | |
| Pubmed | The Gαq/11-provoked induction of Akr1c18 in murine luteal cells is mediated by phospholipase C. | 5.95e-09 | 6 | 157 | 4 | 29107092 | |
| Pubmed | 5.95e-09 | 6 | 157 | 4 | 19273550 | ||
| Pubmed | 5.95e-09 | 6 | 157 | 4 | 15860270 | ||
| Pubmed | 5.95e-09 | 6 | 157 | 4 | 15471942 | ||
| Pubmed | MEF2 and NR2F2 cooperate to regulate Akr1c14 gene expression in mouse MA-10 Leydig cells. | 5.95e-09 | 6 | 157 | 4 | 26748576 | |
| Pubmed | 5.95e-09 | 6 | 157 | 4 | 17122075 | ||
| Pubmed | Decidual prolactin silences the expression of genes detrimental to pregnancy. | 5.95e-09 | 6 | 157 | 4 | 17255200 | |
| Pubmed | 1.38e-08 | 7 | 157 | 4 | 26160177 | ||
| Pubmed | Aldo-ketoreductase 1c19 ablation does not affect insulin secretion in murine islets. | 1.38e-08 | 7 | 157 | 4 | 34843575 | |
| Pubmed | 1.38e-08 | 7 | 157 | 4 | 22529366 | ||
| Pubmed | 1.38e-08 | 7 | 157 | 4 | 33127481 | ||
| Pubmed | 1.38e-08 | 7 | 157 | 4 | 12562828 | ||
| Pubmed | 1.38e-08 | 7 | 157 | 4 | 16337335 | ||
| Pubmed | Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. | 2.76e-08 | 8 | 157 | 4 | 15257293 | |
| Pubmed | 2.76e-08 | 8 | 157 | 4 | 33584538 | ||
| Pubmed | 2.76e-08 | 8 | 157 | 4 | 20837989 | ||
| Pubmed | 2.76e-08 | 8 | 157 | 4 | 9224647 | ||
| Pubmed | RPL26 FLOT2 AMPH ANK3 CLIP2 TCP1 DOCK8 PCLO PABPC4 NIPSNAP1 PHB2 FAM98A NDUFS1 PITPNM1 SPTBN4 AP2A2 AP2B1 SYNJ1 VPS35 XRN1 MACF1 ALDH1B1 ALDOC KPNA3 | 3.05e-08 | 1431 | 157 | 24 | 37142655 | |
| Pubmed | STARD13 KNTC1 RPL26 MYH1 PCLO PABPC4 PHB2 CHD2 FAM98A NEB ZEB2 NDUFS1 SPTBN4 AP2A2 AP2B1 RPL26L1 VPS35 XRN1 MACF1 PABPC1L ALDH1B1 PREX1 MYBPC1 MYBPC2 | 3.52e-08 | 1442 | 157 | 24 | 35575683 | |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | FLOT2 TCP1 PHB2 RNF213 FAM98A AKR1C2 MYO5C AP2A2 AP2B1 AKR1C3 SRRM2 | 4.30e-08 | 268 | 157 | 11 | 33024031 |
| Pubmed | Substrate-driven assembly of a translocon for multipass membrane proteins. | 4.95e-08 | 9 | 157 | 4 | 36261522 | |
| Pubmed | 4.95e-08 | 9 | 157 | 4 | 33348080 | ||
| Pubmed | PABPC4 PHB2 WNK1 NOMO1 COL18A1 THOP1 NOMO2 XRN1 PARN ALDH1B1 SRRM2 NOMO3 | 6.72e-08 | 347 | 157 | 12 | 15231747 | |
| Pubmed | Lack of placental neurosteroid alters cortical development and female somatosensory function. | 8.22e-08 | 10 | 157 | 4 | 36313771 | |
| Pubmed | 9.02e-08 | 3 | 157 | 3 | 19320734 | ||
| Pubmed | Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis. | 9.02e-08 | 3 | 157 | 3 | 31780644 | |
| Pubmed | 9.02e-08 | 3 | 157 | 3 | 7626489 | ||
| Pubmed | 9.02e-08 | 3 | 157 | 3 | 21232532 | ||
| Pubmed | 9.02e-08 | 3 | 157 | 3 | 13678667 | ||
| Pubmed | 9.02e-08 | 3 | 157 | 3 | 36011023 | ||
| Pubmed | 9.02e-08 | 3 | 157 | 3 | 22767497 | ||
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 9.02e-08 | 3 | 157 | 3 | 25576386 | |
| Pubmed | HK3 ANK3 PEG3 FAM91A1 CHD2 AKR1C4 ITGA9 WNK1 ATXN1L AKR1C1 AKR1C2 COL18A1 THOP1 SYNJ1 AKR1C3 MACF1 HERC1 CAMTA1 VPS13B KPNA3 | 1.07e-07 | 1084 | 157 | 20 | 11544199 | |
| Pubmed | Histone H3 lysine 9 methyltransferases, G9a and GLP are essential for cardiac morphogenesis. | 1.07e-07 | 26 | 157 | 5 | 23892084 | |
| Pubmed | An ER translocon for multi-pass membrane protein biogenesis. | 1.29e-07 | 11 | 157 | 4 | 32820719 | |
| Pubmed | 1.59e-07 | 28 | 157 | 5 | 21820362 | ||
| Pubmed | Endogenous biotin as a marker of adrenocortical cells with steroidogenic potential. | 1.92e-07 | 12 | 157 | 4 | 21256921 | |
| Pubmed | Timing of adrenal regression controlled by synergistic interaction between Sf1 SUMOylation and Dax1. | 1.92e-07 | 12 | 157 | 4 | 28893949 | |
| Pubmed | 1.92e-07 | 12 | 157 | 4 | 25774556 | ||
| Pubmed | 2.77e-07 | 13 | 157 | 4 | 11682476 | ||
| Pubmed | 2.77e-07 | 13 | 157 | 4 | 17062636 | ||
| Pubmed | A link between lung androgen metabolism and the emergence of mature epithelial type II cells. | 2.77e-07 | 13 | 157 | 4 | 15117747 | |
| Pubmed | 2.77e-07 | 13 | 157 | 4 | 24580729 | ||
| Pubmed | RPL26 FLOT2 ERCC6L DOCK8 MARCHF6 RNF213 NUF2 PSTPIP1 NCLN TTK BTN3A2 NOMO1 BTN3A3 AP2B1 XRN1 PEX16 GOLIM4 BZW1 HEATR5B ACAP2 | 3.49e-07 | 1168 | 157 | 20 | 19946888 | |
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 3.60e-07 | 4 | 157 | 3 | 31833031 | |
| Pubmed | Primate-specific BTN3A2 protects against SARS-CoV-2 infection by interacting with and reducing ACE2. | 3.60e-07 | 4 | 157 | 3 | 39142074 | |
| Pubmed | 3.60e-07 | 4 | 157 | 3 | 9267806 | ||
| Pubmed | 3.86e-07 | 14 | 157 | 4 | 19955443 | ||
| Pubmed | Placental endocrine function shapes cerebellar development and social behavior. | 3.86e-07 | 14 | 157 | 4 | 34400844 | |
| Pubmed | PEG3 CHD2 NEB KMT2E WNK1 AKR1C2 NDUFS1 GPC3 XIRP2 MED12L MACF1 MYBPC1 MYBPC2 | 4.65e-07 | 497 | 157 | 13 | 23414517 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | SUPT20H ANK3 ZMYND8 CHD2 NCLN NEB PPP1R10 ZNF106 KIF2B XIRP2 VPS35 SHPRH HERC1 | 4.65e-07 | 497 | 157 | 13 | 36774506 |
| Pubmed | WDFY4 is required for cross-presentation in response to viral and tumor antigens. | 5.94e-07 | 156 | 157 | 8 | 30409884 | |
| Pubmed | 8.97e-07 | 5 | 157 | 3 | 29339503 | ||
| Pubmed | 8.97e-07 | 5 | 157 | 3 | 15212687 | ||
| Pubmed | 9.09e-07 | 17 | 157 | 4 | 32243503 | ||
| Pubmed | 9.34e-07 | 225 | 157 | 9 | 12168954 | ||
| Pubmed | VRK2 SUPT20H PABPC4 ZMYND8 PUSL1 SRP19 FAM91A1 CHD2 FAM98A TBL1XR1 NDUFS1 NOMO1 PPP1R10 COL18A1 XRN1 GOLIM4 MACF1 PARN HEATR5B ANAPC5 PREX1 KPNA3 | 1.13e-06 | 1497 | 157 | 22 | 31527615 | |
| Pubmed | FLOT2 ANK3 PABPC4 SRP19 TBL1XR1 PPP1R10 ZNF106 AP2A2 AP2B1 GOLIM4 SMARCD1 MACF1 WDR48 KPNA3 | 1.24e-06 | 634 | 157 | 14 | 34591612 | |
| Pubmed | Functional dynamics of H3K9 methylation during meiotic prophase progression. | 1.47e-06 | 19 | 157 | 4 | 17599069 | |
| Interaction | AKR1C4 interactions | 2.13e-07 | 8 | 152 | 4 | int:AKR1C4 | |
| Interaction | AKR1C3 interactions | 8.20e-06 | 37 | 152 | 5 | int:AKR1C3 | |
| Interaction | KIF20A interactions | RPL26 FLOT2 PCLO PABPC4 PHB2 CHD2 FAM98A ZEB2 SPTBN4 ZNF106 AP2A2 AP2B1 RPL26L1 XRN1 MACF1 PABPC1L SH3BP5L ALDH1B1 HERC1 SRRM2 SCIN CDH9 | 1.36e-05 | 1052 | 152 | 22 | int:KIF20A |
| Interaction | AKR1C1 interactions | 1.37e-05 | 20 | 152 | 4 | int:AKR1C1 | |
| Interaction | XIRP2 interactions | 3.01e-05 | 48 | 152 | 5 | int:XIRP2 | |
| Interaction | CIT interactions | RPL26 FLOT2 VRK2 TCP1 MYO1H PCLO PABPC4 NIPSNAP1 ZMYND8 PHB2 RNF213 CHD2 FAM98A NUF2 ADGRV1 SPTBN4 MTMR4 AP2A2 AP2B1 RPL26L1 MACF1 PABPC1L HERC1 SRRM2 TARBP1 KPNA3 | 3.07e-05 | 1450 | 152 | 26 | int:CIT |
| Cytoband | 10p15-p14 | 7.64e-07 | 6 | 156 | 3 | 10p15-p14 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10p15 | 2.61e-04 | 90 | 156 | 4 | chr10p15 | |
| GeneFamily | Aldo-keto reductases | 1.19e-06 | 15 | 101 | 4 | 399 | |
| GeneFamily | Butyrophilins|V-set domain containing|C2-set domain containing | 7.33e-05 | 15 | 101 | 3 | 458 | |
| GeneFamily | PHD finger proteins | 1.49e-04 | 90 | 101 | 5 | 88 | |
| GeneFamily | Fibronectin type III domain containing|I-set domain containing|Myosin binding proteins | 8.46e-04 | 8 | 101 | 2 | 658 | |
| GeneFamily | CD molecules|Type II classical cadherins | 2.32e-03 | 13 | 101 | 2 | 1186 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | RPL26 SEMA4D FLOT2 TCP1 DOCK8 GIMAP2 KAT6A MARCHF6 RNF213 CHD2 PSTPIP1 KMT2E WNK1 TBL1XR1 WDR26 BTN3A2 BTN3A1 ZEB2 KMT2D EPC1 XRN1 OXNAD1 MACF1 BZW1 HERC1 ACAP2 PREX1 VPS13B ARAP2 SOS1 | 3.24e-09 | 1492 | 155 | 30 | M40023 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | KNTC1 DOCK8 WNK1 PPP1R10 ZNF106 MED12L SMARCD1 MACF1 HERC1 ARAP2 SOS1 | 1.08e-08 | 180 | 155 | 11 | M8239 |
| Coexpression | IRITANI_MAD1_TARGETS_UP | 3.96e-08 | 17 | 155 | 5 | MM826 | |
| Coexpression | DELYS_THYROID_CANCER_DN | 1.35e-06 | 233 | 155 | 10 | M13273 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_BCELL_UP | 2.78e-06 | 197 | 155 | 9 | M4985 | |
| Coexpression | GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_DN | 2.90e-06 | 198 | 155 | 9 | M4981 | |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3 | 7.56e-06 | 79 | 155 | 6 | MM535 | |
| Coexpression | BUSSLINGER_DUODENAL_IMMUNE_CELLS | RPL26 SEMA4D FLOT2 DOCK8 GIMAP2 KAT6A CHD2 PSTPIP1 KMT2E WNK1 WDR26 BTN3A1 OXNAD1 MACF1 BZW1 HERC1 PREX1 ARAP2 | 7.90e-06 | 911 | 155 | 18 | M40038 |
| Coexpression | LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK | 1.14e-05 | 24 | 155 | 4 | MM766 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN | 1.35e-05 | 25 | 155 | 4 | MM480 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP | 1.50e-05 | 185 | 155 | 8 | MM1115 | |
| Coexpression | RICKMAN_HEAD_AND_NECK_CANCER_F | 1.86e-05 | 55 | 155 | 5 | M2043 | |
| Coexpression | GSE11924_TH1_VS_TH17_CD4_TCELL_DN | 2.54e-05 | 199 | 155 | 8 | M3163 | |
| Coexpression | GSE27786_LIN_NEG_VS_MONO_MAC_DN | 2.64e-05 | 200 | 155 | 8 | M4798 | |
| Coexpression | GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_MAC_UP | 2.64e-05 | 200 | 155 | 8 | M5165 | |
| Coexpression | DARWICHE_PAPILLOMA_RISK_HIGH_DN | 2.73e-05 | 201 | 155 | 8 | MM500 | |
| Coexpression | MARSON_FOXP3_TARGETS_DN | 2.85e-05 | 60 | 155 | 5 | MM847 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS | 2.86e-05 | 30 | 155 | 4 | MM853 | |
| Coexpression | LI_CISPLATIN_RESISTANCE_DN | 4.21e-05 | 33 | 155 | 4 | M10150 | |
| Coexpression | GOLDRATH_IMMUNE_MEMORY | 5.62e-05 | 69 | 155 | 5 | MM621 | |
| Coexpression | DESCARTES_ORGANOGENESIS_INTERMEDIATE_MESODERM | 5.98e-05 | 36 | 155 | 4 | MM3660 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM | 6.66e-05 | 228 | 155 | 8 | MM1014 | |
| Coexpression | WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP | 6.67e-05 | 37 | 155 | 4 | MM630 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | AMPH DHRS3 MARCHF6 SRP19 AKR1C4 NUF2 ITGA9 TTK WDR26 AKR1C1 BTN3A2 AKR1C2 BTN3A1 ATP10D BTN3A3 AP2A2 AKR1C3 HERC1 ANAPC5 KPNA3 | 6.79e-05 | 1277 | 155 | 20 | MM1032 |
| Coexpression | GSE3920_IFNA_VS_IFNG_TREATED_FIBROBLAST_UP | 8.51e-05 | 175 | 155 | 7 | M6690 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | SUPT20H DHRS3 RNF213 CHD2 CACHD1 TBL1XR1 AKR1C1 ZEB2 KIF9 CPQ PDGFD HERC1 SRRM2 ANAPC5 REV1 | 9.32e-05 | 807 | 155 | 15 | M16651 |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | STARD13 PEG3 CHD2 NUF2 HUNK WNK1 TBL1XR1 TTK ZEB2 NDUFS1 COL18A1 GPC3 XRN1 PARN CDH4 PREX1 VPS13B | 1.04e-04 | 1009 | 155 | 17 | M157 |
| Coexpression | HOWARD_NEUTROPHIL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP | VRK2 GIMAP2 RNF213 PSTPIP2 ATP10D RBCK1 BTN3A3 XRN1 MED12L TARBP1 | 1.25e-04 | 394 | 155 | 10 | M40996 |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | MYH1 ANK3 PEG3 PHB2 AKR1C4 ITGA9 AKR1C1 AKR1C2 ITIH5 ZNF106 UCP3 AKR1C3 BZW1 WDR48 | 1.36e-04 | 741 | 155 | 14 | MM1037 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN | 1.44e-04 | 84 | 155 | 5 | M13008 | |
| Coexpression | VARELA_ZMPSTE24_TARGETS_DN | 1.45e-04 | 45 | 155 | 4 | MM1173 | |
| Coexpression | DARWICHE_PAPILLOMA_RISK_LOW_UP | 1.51e-04 | 192 | 155 | 7 | MM497 | |
| Coexpression | HEVNER_CORTICAL_PLATE_POSTMITOTIC_NEURONS | 1.62e-04 | 136 | 155 | 6 | MM407 | |
| Coexpression | GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_UP | 1.67e-04 | 195 | 155 | 7 | M3184 | |
| Coexpression | GSE12366_GC_VS_NAIVE_BCELL_DN | 1.67e-04 | 195 | 155 | 7 | M3170 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | STARD13 AMPH SUPT20H KAT6A MARCHF6 ZMYND8 TTK ZEB2 MACF1 PARN ACAP2 VPS13B ARAP2 SOS1 KPNA3 | 1.77e-04 | 856 | 155 | 15 | M4500 |
| Coexpression | GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP | 1.77e-04 | 197 | 155 | 7 | M7545 | |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH1_UP | 1.77e-04 | 197 | 155 | 7 | M5378 | |
| Coexpression | EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION | 1.87e-04 | 48 | 155 | 4 | M16123 | |
| Coexpression | GSE40685_TREG_VS_FOXP3_KO_TREG_PRECURSOR_UP | 1.89e-04 | 199 | 155 | 7 | M9306 | |
| Coexpression | GSE22140_GERMFREE_VS_SPF_ARTHRITIC_MOUSE_CD4_TCELL_DN | 1.89e-04 | 199 | 155 | 7 | M7645 | |
| Coexpression | GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_DN | 1.89e-04 | 199 | 155 | 7 | M3070 | |
| Coexpression | MASSARWEH_TAMOXIFEN_RESISTANCE_UP | ANK3 DHRS3 PSTPIP2 ATXN1L WDR26 PITPNM1 SYNJ1 TRIM62 BZW1 PREX1 VPS13B ARAP2 | 1.90e-04 | 583 | 155 | 12 | M17454 |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_B | PCLO MARCHF6 AKR1C4 ITGA9 WNK1 TBL1XR1 AKR1C1 AKR1C2 NDUFS1 PPP1R10 AKR1C3 ANAPC5 | 1.93e-04 | 584 | 155 | 12 | MM1080 |
| Coexpression | GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_DN | 1.95e-04 | 200 | 155 | 7 | M7162 | |
| Coexpression | GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_DN | 1.95e-04 | 200 | 155 | 7 | M8485 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4MID_SORTED_BCELL_DN | 1.95e-04 | 200 | 155 | 7 | M9837 | |
| Coexpression | GSE360_CTRL_VS_L_DONOVANI_MAC_UP | 1.95e-04 | 200 | 155 | 7 | M5157 | |
| Coexpression | GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_UP | 1.95e-04 | 200 | 155 | 7 | M5261 | |
| Coexpression | GSE3982_BASOPHIL_VS_TH2_UP | 1.95e-04 | 200 | 155 | 7 | M5566 | |
| Coexpression | DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN | 2.01e-04 | 201 | 155 | 7 | MM502 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_SCG3_POS_LYMPHATIC_ENDOTHELIAL_CELL | SEMA4D PCLO ZMYND8 FAM98A ITGA9 AKR1C1 AKR1C2 ATP10D MYO5C PITPNM1 PDGFD AKR1C3 | 2.63e-04 | 604 | 155 | 12 | M45760 |
| Coexpression | MULLIGHAN_MLL_SIGNATURE_2_DN | 2.66e-04 | 279 | 155 | 8 | M16867 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | ANK3 PCLO PEG3 ZMYND8 NEB KMT2E AKR1C1 AKR1C2 KCNC1 SYNJ1 RASGEF1B HERC1 CAMTA1 SCIN CDH4 TARBP1 PDZRN4 | 3.07e-04 | 1106 | 155 | 17 | M39071 |
| Coexpression | FAN_EMBRYONIC_CTX_ASTROCYTE_2 | 3.17e-04 | 154 | 155 | 6 | M39034 | |
| Coexpression | RUIZ_TNC_TARGETS_UP | 3.40e-04 | 156 | 155 | 6 | M988 | |
| Coexpression | VERHAAK_GLIOBLASTOMA_CLASSICAL | 4.02e-04 | 161 | 155 | 6 | M2121 | |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A | DHRS3 ENPP1 MYO1H CDHR5 AKR1C4 NCLN ITGA9 AKR1C1 AKR1C2 ZEB2 MYO5C ACAN XRN1 AKR1C3 EVI5L | 4.27e-04 | 930 | 155 | 15 | MM893 |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | DOCK8 RNF213 CHD2 KMT2E ZEB2 RASGEF1B XRN1 MACF1 SRRM2 ARAP2 | 2.40e-09 | 200 | 156 | 10 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-08 | 176 | 156 | 9 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-08 | 182 | 156 | 9 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-07 | 183 | 156 | 8 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-07 | 183 | 156 | 8 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 3.03e-07 | 185 | 156 | 8 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.42e-07 | 188 | 156 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.52e-07 | 195 | 156 | 8 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-41|World / Primary Cells by Cluster | 4.70e-07 | 196 | 156 | 8 | dee0984cd63a1a2fdebb4421af48ab566a5b684e | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.88e-07 | 197 | 156 | 8 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|lung / Disease (COVID-19 only), tissue and cell type | 4.88e-07 | 197 | 156 | 8 | a0f8a992282a6d64890f5574c7c9741fcb38dadd | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.07e-07 | 198 | 156 | 8 | ea34096bee852a7e996f097fa279381afa8f86ff | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 5.27e-07 | 199 | 156 | 8 | df4f7d5be099e3e6054f3b812ccf70251664e4c0 | |
| ToppCell | COVID_vent-Lymphocytic-ILC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 5.27e-07 | 199 | 156 | 8 | e3ff7fa1b1de1aaf6b46cdf49afa95bad457728a | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 5.27e-07 | 199 | 156 | 8 | ed35d747f11f6ea6a5cb7061057f0a98d9e0db99 | |
| ToppCell | COVID_vent-Lymphocytic-ILC-NK_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 5.27e-07 | 199 | 156 | 8 | 5f914962e2572b0c6372465b81b7496fa663d93c | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.45e-06 | 171 | 156 | 7 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 3.57e-06 | 181 | 156 | 7 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-06 | 184 | 156 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 4.27e-06 | 186 | 156 | 7 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.42e-06 | 187 | 156 | 7 | ec4b694487cc446999c7b27b119950a4f252c4b3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.42e-06 | 187 | 156 | 7 | 530e4e6d91b5c0d9aa4543caa2b734a1674c5788 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.58e-06 | 188 | 156 | 7 | 9abd78970bbe4ed03b59a83da63bbd334712f605 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.58e-06 | 188 | 156 | 7 | 5ae8ccdd328cf117da1d01ced2c3b7f763a5f1f1 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.91e-06 | 190 | 156 | 7 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | COVID-19-lung-CD4+_Treg|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.08e-06 | 191 | 156 | 7 | 5a4ad5ae5c2dbfb225158cb598ef649c26a48350 | |
| ToppCell | background-Cholangiocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.08e-06 | 191 | 156 | 7 | 99aa8d685767a72bef9f05e7cc8913126a048c39 | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 5.08e-06 | 191 | 156 | 7 | a7bb8aba9c59c037d995a77928cc7b4d5cbb82b9 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.44e-06 | 193 | 156 | 7 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | background-Cholangiocytes|background / Sample and Cell Type and Tumor Cluster (all cells) | 5.44e-06 | 193 | 156 | 7 | 9152241073dbe02ac2c11d86bec9b5b529196f6e | |
| ToppCell | facs-Pancreas-Exocrine-3m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-06 | 193 | 156 | 7 | c3161a14a40323a58aa202c8a1d6ea0e9c2b9814 | |
| ToppCell | Adult-Immune-monocyte-D122|Adult / Lineage, Cell type, age group and donor | 6.02e-06 | 196 | 156 | 7 | 16b0acb6157534938ca83d4e909471e33a7d3c52 | |
| ToppCell | Mild-CD8+_T_activated|World / Disease group and Cell class | 6.02e-06 | 196 | 156 | 7 | 79632190e44fcef9d7c11d9b9e37f2ebf0e6e255 | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.22e-06 | 197 | 156 | 7 | e42910a653a1b5bd90c090e9665a84871ed2873f | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 6.22e-06 | 197 | 156 | 7 | d4dfb3b561d0783cdbee4e8d27009ad81df695cb | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.43e-06 | 198 | 156 | 7 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.65e-06 | 199 | 156 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.65e-06 | 199 | 156 | 7 | f1d5808ccb1d5d4e2d34f864e705e2484000e88f | |
| ToppCell | VE-CD4-antiviral_CD4|VE / Condition, Cell_class and T cell subcluster | 6.65e-06 | 199 | 156 | 7 | 056a0538ca5e825ae6195b4c76c208708a014533 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 6.65e-06 | 199 | 156 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_CTL|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.65e-06 | 199 | 156 | 7 | eb188b0b457136b6ee485d3b3052baa30d9c0002 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 6.87e-06 | 200 | 156 | 7 | 1decf1d2cba5ebfd3e5cd4bcd637db8f193033ce | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 6.87e-06 | 200 | 156 | 7 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 6.87e-06 | 200 | 156 | 7 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T|COVID-19_Severe / Disease, condition lineage and cell class | 6.87e-06 | 200 | 156 | 7 | f72bc3f6606ae77fe1b0a972e35b3ce0727804d9 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.33e-05 | 147 | 156 | 6 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | COVID-19_Moderate-multiplets|World / disease group, cell group and cell class | 1.87e-05 | 156 | 156 | 6 | afdc025fa75e7926b1cc182c4a33654a2186abb1 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.94e-05 | 157 | 156 | 6 | 6ee2692f705bdd93ba523dffaf2f0cd921b47e28 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-intermediate_monocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.01e-05 | 158 | 156 | 6 | b35bab2b93d0af821bfae18a358eb7dddaf3860f | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.01e-05 | 158 | 156 | 6 | 7bd4a64a610eb1cbcd3d07ea5258a55107cf6c00 | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.39e-05 | 163 | 156 | 6 | e6213900f56257fe38ac7852351bea0340294be0 | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.39e-05 | 163 | 156 | 6 | ed7319185c1ec384444309bb8be95691a0c2091c | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.39e-05 | 163 | 156 | 6 | ef35d7ff09aa364734fea7fdaab6260c0a3fbf09 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.74e-05 | 167 | 156 | 6 | a54b8e03987a7b067173121902e1811a3d003692 | |
| ToppCell | Substantia_nigra-Macroglia-OLIGODENDROCYTE-O2-Tnr-Oligodendrocyte.Tnr.Rps24_(Rps24)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.85e-05 | 101 | 156 | 5 | c075aa59acf333b05b6533b8172dc0c5c31b6ed3 | |
| ToppCell | Substantia_nigra-Macroglia-OLIGODENDROCYTE-O2-Tnr-Oligodendrocyte.Tnr.Rps24_(Rps24)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.85e-05 | 101 | 156 | 5 | be1c3034c2ebe64b7dd7a9b31ea43336ea1eeb73 | |
| ToppCell | Substantia_nigra-Macroglia-OLIGODENDROCYTE-O2-Tnr|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.85e-05 | 101 | 156 | 5 | 8ce6ebda05081dbd7db891e5da8af9cc7d4beacb | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.03e-05 | 170 | 156 | 6 | 8465c3069bbc08705d070927e712b6bc85ac7c5b | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.13e-05 | 171 | 156 | 6 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 3.13e-05 | 171 | 156 | 6 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-NK_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.23e-05 | 172 | 156 | 6 | f3c16a62eba1ed190318beee131c71c5150b266a | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-iNKT/MAIT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.45e-05 | 174 | 156 | 6 | 61aa89b56ebda0eba1ba675d5f036992967f670f | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-skeletal_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-05 | 174 | 156 | 6 | 4a6e04b4f12b87c15fa1409989cbe32c43736369 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.56e-05 | 175 | 156 | 6 | 97616bb5c127284aa9e67bc336dfcf29e137164b | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.56e-05 | 175 | 156 | 6 | fd8b5b756f3df4a04938785f3d9edbb6f1cd20f6 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.56e-05 | 175 | 156 | 6 | 36c140540497bbe1c5f08fac2d94f08cac18fabb | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 3.68e-05 | 176 | 156 | 6 | 36f77d878a53b30465b0dea8333a3865dba75613 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-1|TCGA-Liver / Sample_Type by Project: Shred V9 | 3.92e-05 | 178 | 156 | 6 | 51c59dabf2d7aef1b1964f6f766d5ec07ef90f5a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_IL7R|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.30e-05 | 181 | 156 | 6 | b9fe3833a6a56b9fbe5c257393fdbea5bf8ac4a3 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_pre_proliferating_SCP_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.43e-05 | 182 | 156 | 6 | bfb725fff3d20066d8ac0a6ba2f88498fcbd876e | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.43e-05 | 182 | 156 | 6 | b4fc5e4f5d8440a3c9ee0a6fd0da87b43cabc8c6 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-05 | 182 | 156 | 6 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP2_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.43e-05 | 182 | 156 | 6 | f7f9be9c7ef8da9864d6aefe20043b26e1bb8697 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-skeletal_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-05 | 182 | 156 | 6 | edfc598b7199ca1d8a399b264ab863c299b1eede | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.57e-05 | 183 | 156 | 6 | 547b1fb9f9940cfc8d6e351d96acc0da44def57e | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-05 | 184 | 156 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-05 | 184 | 156 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-05 | 184 | 156 | 6 | 10706441e7695212f95689414f31e8082b5eaf0a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-05 | 184 | 156 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-05 | 184 | 156 | 6 | 4bb0976a75126ad2b3deb5d2229f0716fafe200e | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 4.86e-05 | 185 | 156 | 6 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 4.86e-05 | 185 | 156 | 6 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.86e-05 | 185 | 156 | 6 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.86e-05 | 185 | 156 | 6 | a8946379fc066903fe8f4bc9cbf693b7b424a0cd | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.86e-05 | 185 | 156 | 6 | dd17025d8c423aa0a451ac7f1f301c93528e0229 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-skeletal_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.86e-05 | 185 | 156 | 6 | 9245c322aae8bb9065d50dada198a5ee143a3444 | |
| ToppCell | COVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.16e-05 | 187 | 156 | 6 | d23aae9419d460b78b1d4092d7acd9108a47cfbe | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic_-_developing-thymocyte|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.31e-05 | 188 | 156 | 6 | bcfc426b60d8e5a23a2360bfb68b32868fec9fbf | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.31e-05 | 188 | 156 | 6 | f7dc29dfec68236883469e848be5db34f5526d6b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.31e-05 | 188 | 156 | 6 | 15146fd2c5592ea84d20b1fdd172b39cd60b5bed | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.31e-05 | 188 | 156 | 6 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 5.47e-05 | 189 | 156 | 6 | 9c407b17d7945e81e1ae6c18452f5d20fb09d563 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-skeletal_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.47e-05 | 189 | 156 | 6 | d2b008f98739c6af7ee63b643011a240db20e4d8 | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 5.47e-05 | 189 | 156 | 6 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.63e-05 | 190 | 156 | 6 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.63e-05 | 190 | 156 | 6 | 5681c211baeed4af82a2bbc13420f6a7b487581c | |
| ToppCell | wk_08-11-Epithelial-PNS-Schwann_precursor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.63e-05 | 190 | 156 | 6 | 4a777d8aa19cadd3b61b023772df142421a89113 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.80e-05 | 191 | 156 | 6 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.80e-05 | 191 | 156 | 6 | 273c4a757292a9301de0eaeacdec91c9866be229 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.80e-05 | 191 | 156 | 6 | f9a46956778a8773d6656340ecf5d218376d79c2 | |
| Computational | Neighborhood of TTN | 1.17e-04 | 26 | 107 | 4 | GNF2_TTN | |
| Computational | Neighborhood of CASP8 | 1.37e-04 | 27 | 107 | 4 | GNF2_CASP8 | |
| Computational | Neighborhood of SNRK | 1.58e-04 | 28 | 107 | 4 | GNF2_SNRK | |
| Drug | cloxazolam | 1.96e-09 | 4 | 153 | 4 | ctd:C005522 | |
| Drug | Pregnanes | 1.96e-09 | 4 | 153 | 4 | ctd:D011278 | |
| Drug | tetralol | 1.96e-09 | 4 | 153 | 4 | ctd:C019106 | |
| Drug | 3',3'',5',5''-tetrabromophenolphthalein | 1.96e-09 | 4 | 153 | 4 | ctd:C018156 | |
| Drug | Hydroxysteroids | 9.75e-09 | 5 | 153 | 4 | ctd:D006914 | |
| Drug | cresolphthalein | 9.75e-09 | 5 | 153 | 4 | ctd:C010092 | |
| Drug | Medazepam | 2.91e-08 | 6 | 153 | 4 | ctd:D008472 | |
| Drug | Nitrazepam | 1.34e-07 | 8 | 153 | 4 | ctd:D009567 | |
| Drug | 4-hydroxybenzoic acid | 2.41e-07 | 9 | 153 | 4 | ctd:C038193 | |
| Drug | 20-alpha-Dihydroprogesterone | 2.41e-07 | 9 | 153 | 4 | ctd:D004092 | |
| Drug | cyclopentanol | 2.98e-07 | 3 | 153 | 3 | ctd:C016327 | |
| Drug | cyclopentanone | 2.98e-07 | 3 | 153 | 3 | ctd:C007201 | |
| Drug | 5-dihydrodeoxycorticosterone | 2.98e-07 | 3 | 153 | 3 | ctd:C454687 | |
| Drug | 4-benzoylbenzoic acid | 2.98e-07 | 3 | 153 | 3 | ctd:C058818 | |
| Drug | dichloro(4-cymene)ruthenium(II) | 2.98e-07 | 3 | 153 | 3 | ctd:C530610 | |
| Drug | octyl gallate | 3.99e-07 | 10 | 153 | 4 | ctd:C016627 | |
| Drug | Dihydroxydihydrobenzopyrenes | 6.24e-07 | 11 | 153 | 4 | ctd:D004101 | |
| Drug | chlordecone alcohol | 6.24e-07 | 11 | 153 | 4 | CID000013946 | |
| Drug | p-nitrobenzaldehyde | 8.11e-07 | 48 | 153 | 6 | CID000000541 | |
| Drug | Phenolphthalein | 9.31e-07 | 12 | 153 | 4 | ctd:D020113 | |
| Drug | tetrahydrodeoxycorticosterone | 1.18e-06 | 4 | 153 | 3 | ctd:C009413 | |
| Drug | gliquidone | 1.18e-06 | 4 | 153 | 3 | ctd:C010969 | |
| Drug | DBD-H | 1.18e-06 | 4 | 153 | 3 | CID000131382 | |
| Drug | DMBA-3,4-dihydrodiol | 1.34e-06 | 13 | 153 | 4 | CID000050096 | |
| Drug | flunisolide | 1.34e-06 | 13 | 153 | 4 | ctd:C007734 | |
| Drug | 5-alpha-Dihydroprogesterone | 1.86e-06 | 14 | 153 | 4 | ctd:D043582 | |
| Drug | 1-acenaphthenol | 1.86e-06 | 14 | 153 | 4 | CID000022750 | |
| Drug | Meclofenamic Acid | 1.86e-06 | 14 | 153 | 4 | ctd:D008469 | |
| Drug | NSC86000 | 2.95e-06 | 5 | 153 | 3 | CID000257630 | |
| Drug | AC1L93E5 | 5.86e-06 | 6 | 153 | 3 | CID000412383 | |
| Drug | Estazolam | 5.86e-06 | 6 | 153 | 3 | ctd:D004949 | |
| Drug | 3-hydroxyhexobarbital | 5.86e-06 | 6 | 153 | 3 | CID000439898 | |
| Drug | Glipizide | 5.86e-06 | 6 | 153 | 3 | ctd:D005913 | |
| Drug | acenaphthene-1-ol | 5.86e-06 | 6 | 153 | 3 | ctd:C023723 | |
| Drug | oxcarbazepine | 7.02e-06 | 19 | 153 | 4 | ctd:C036006 | |
| Drug | Flucytosine [2022-85-7]; Down 200; 31uM; HL60; HT_HG-U133A | 8.37e-06 | 199 | 153 | 9 | 3073_DN | |
| Drug | benzo(a)pyrene-7,8-dione | 8.74e-06 | 20 | 153 | 4 | ctd:C076588 | |
| Drug | Chrysenes | 8.74e-06 | 20 | 153 | 4 | ctd:D002911 | |
| Drug | 4-hydroxyequilenin-o-quinone | 1.02e-05 | 7 | 153 | 3 | ctd:C117714 | |
| Drug | zomepirac | 1.02e-05 | 7 | 153 | 3 | ctd:C020549 | |
| Drug | Flunitrazepam | 1.07e-05 | 21 | 153 | 4 | ctd:D005445 | |
| Drug | Dutasteride | 1.07e-05 | 21 | 153 | 4 | ctd:D000068538 | |
| Drug | benzene dihydrodiol | 1.31e-05 | 22 | 153 | 4 | CID000000418 | |
| Drug | 2-cyclohexen-1-ol | 1.63e-05 | 8 | 153 | 3 | CID000013198 | |
| Drug | Glycyrrhetinic Acid | 1.88e-05 | 24 | 153 | 4 | ctd:D006034 | |
| Drug | 9,10-phenanthrenequinone | 2.22e-05 | 25 | 153 | 4 | ctd:C005399 | |
| Drug | Pregnanolone | 2.22e-05 | 25 | 153 | 4 | ctd:D011280 | |
| Drug | testosterone enanthate | ANK3 ENPP1 WNK1 AKR1C1 AKR1C2 AP2B1 AKR1C3 GOLIM4 MACF1 ALDH1B1 SRRM2 ANAPC5 SOS1 WDR48 | 3.52e-05 | 575 | 153 | 14 | ctd:C004648 |
| Drug | 1,2-dihydroxynaphthalene | 4.05e-05 | 57 | 153 | 5 | CID000011318 | |
| Drug | alpha-methylcinnamic acid | 4.49e-05 | 2 | 153 | 2 | ctd:C510582 | |
| Drug | (10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE | 4.49e-05 | 2 | 153 | 2 | DB07768 | |
| Drug | baccharin | 4.49e-05 | 2 | 153 | 2 | ctd:C012764 | |
| Drug | benzo(a)pyrene 7,8-dihydrodiol | 5.36e-05 | 31 | 153 | 4 | ctd:C017228 | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; HL60; HG-U133A | 5.99e-05 | 198 | 153 | 8 | 2002_DN | |
| Drug | Tocainide hydrochloride; Up 200; 17.4uM; HL60; HT_HG-U133A | 6.20e-05 | 199 | 153 | 8 | 2931_UP | |
| Drug | fenamic acid | 6.26e-05 | 12 | 153 | 3 | ctd:C001209 | |
| Drug | Ethosuximide [77-67-8]; Down 200; 28.4uM; PC3; HT_HG-U133A | 6.43e-05 | 200 | 153 | 8 | 7308_DN | |
| Drug | Epivincamine [6835-99-0]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 6.43e-05 | 200 | 153 | 8 | 6838_UP | |
| Drug | Furazolidone [67-45-8]; Up 200; 17.8uM; HL60; HT_HG-U133A | 6.43e-05 | 200 | 153 | 8 | 3019_UP | |
| Drug | 4-formyl-benzoate | 8.10e-05 | 13 | 153 | 3 | CID000012088 | |
| Drug | Dydrogesterone | 1.03e-04 | 14 | 153 | 3 | ctd:D004394 | |
| Drug | 6-.beta.-Naltrexol | 1.03e-04 | 14 | 153 | 3 | CID000631219 | |
| Drug | 5 beta-pregnane-3,20-dione | 1.25e-04 | 72 | 153 | 5 | CID000092745 | |
| Drug | drospirenone | 1.28e-04 | 15 | 153 | 3 | ctd:C035144 | |
| Drug | Mefenamic Acid | 1.34e-04 | 39 | 153 | 4 | ctd:D008528 | |
| Drug | 20 alpha-dihydroprogesterone | 1.48e-04 | 40 | 153 | 4 | CID000008956 | |
| Drug | 9-cis-retinal | 1.56e-04 | 16 | 153 | 3 | ctd:C031390 | |
| Drug | o-quinone | 1.64e-04 | 41 | 153 | 4 | CID000011421 | |
| Drug | bu-b | 1.72e-04 | 77 | 153 | 5 | CID000351065 | |
| Drug | benzo(a)pyrene-1,6-quinone | 1.89e-04 | 17 | 153 | 3 | ctd:C030233 | |
| Drug | cloxazolam | 2.25e-04 | 18 | 153 | 3 | CID000002816 | |
| Drug | Ruthenium Compounds | 2.25e-04 | 18 | 153 | 3 | ctd:D017975 | |
| Drug | benzo(a)pyrene-3,6-quinone | 2.25e-04 | 18 | 153 | 3 | ctd:C018003 | |
| Drug | 1,10-phenanthroline | 2.31e-04 | 82 | 153 | 5 | ctd:C025205 | |
| Drug | Flufenamic Acid | 2.36e-04 | 45 | 153 | 4 | ctd:D005439 | |
| Drug | naphthalene-1,2-dihydrodiol | 2.36e-04 | 45 | 153 | 4 | CID000000362 | |
| Drug | AC1L8ZBW | 2.66e-04 | 19 | 153 | 3 | CID000435356 | |
| Drug | N,N-Dibenzylethanolamine | 2.67e-04 | 4 | 153 | 2 | CID000022656 | |
| Disease | Neoplasms, Hormone-Dependent | 1.42e-07 | 3 | 155 | 3 | C0027661 | |
| Disease | Hermaphroditism | 1.41e-06 | 5 | 155 | 3 | C0019269 | |
| Disease | Ambiguous Genitalia | 1.41e-06 | 5 | 155 | 3 | C0266362 | |
| Disease | Pseudohermaphroditism | 1.41e-06 | 5 | 155 | 3 | C0033804 | |
| Disease | Intersex Conditions | 1.41e-06 | 5 | 155 | 3 | C2930618 | |
| Disease | Sex Differentiation Disorders | 1.41e-06 | 5 | 155 | 3 | C2930619 | |
| Disease | Disorders of Sex Development | 4.90e-06 | 7 | 155 | 3 | C0036875 | |
| Disease | MALE PSEUDOHERMAPHRODITISM: DEFICIENCY OF TESTICULAR 17,20-DESMOLASE | 2.74e-05 | 2 | 155 | 2 | C1839840 | |
| Disease | 46,XY disorder of sex development due to testicular 17,20-desmolase deficiency | 2.74e-05 | 2 | 155 | 2 | cv:C1839840 | |
| Disease | 46,XY sex reversal 8 (is_implicated_in) | 2.74e-05 | 2 | 155 | 2 | DOID:0111773 (is_implicated_in) | |
| Disease | 46,XY SEX REVERSAL 8 | 2.74e-05 | 2 | 155 | 2 | 614279 | |
| Disease | cognitive function measurement | PPP4R1 KNTC1 SEMA4D FLOT2 VRK2 LAMC3 CHD2 THSD7B KMT2E BTN3A2 SNURFL KMT2D MED12L BZW1 CDH4 PREX1 CDH9 MYBPC2 SOS1 REV1 | 6.61e-05 | 1434 | 155 | 20 | EFO_0008354 |
| Disease | response to methotrexate | 7.57e-05 | 16 | 155 | 3 | GO_0031427 | |
| Disease | Fetal Alcohol Syndrome | 9.16e-05 | 17 | 155 | 3 | C0015923 | |
| Disease | migraine disorder | 1.20e-04 | 357 | 155 | 9 | MONDO_0005277 | |
| Disease | Acne Vulgaris | 1.63e-04 | 4 | 155 | 2 | C0001144 | |
| Disease | Acne | 1.63e-04 | 4 | 155 | 2 | C0702166 | |
| Disease | Pyoderma Gangrenosum | 1.63e-04 | 4 | 155 | 2 | C0085652 | |
| Disease | platelet component distribution width | SUPT20H DOCK8 ZMYND8 WNK1 COL18A1 KIF9 AP2B1 EPC1 MACF1 HERC1 CAMTA1 PREX1 MYBPC1 | 1.86e-04 | 755 | 155 | 13 | EFO_0007984 |
| Disease | Headache | 3.64e-04 | 64 | 155 | 4 | HP_0002315 | |
| Disease | glucagon measurement, glucose tolerance test | 4.06e-04 | 6 | 155 | 2 | EFO_0004307, EFO_0008463 | |
| Disease | cortolone glucuronide (1) measurement | 4.06e-04 | 6 | 155 | 2 | EFO_0800552 | |
| Disease | Hidradenitis Suppurativa | 5.66e-04 | 7 | 155 | 2 | C0162836 | |
| Disease | response to 5-fluorouracil, response to antineoplastic agent | 5.66e-04 | 7 | 155 | 2 | GO_0036275, GO_0097327 | |
| Disease | central serous retinopathy | 7.52e-04 | 8 | 155 | 2 | EFO_0009784 | |
| Disease | blindness (implicated_via_orthology) | 7.52e-04 | 8 | 155 | 2 | DOID:1432 (implicated_via_orthology) | |
| Disease | Sclerocystic Ovaries | 1.00e-03 | 144 | 155 | 5 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 1.00e-03 | 144 | 155 | 5 | C0032460 | |
| Disease | Inherited obesity | 1.20e-03 | 10 | 155 | 2 | cv:C4054476 | |
| Disease | Obesity | 1.20e-03 | 10 | 155 | 2 | cv:C0028754 | |
| Disease | OBESITY | 1.20e-03 | 10 | 155 | 2 | 601665 | |
| Disease | prostate cancer (is_marker_for) | 1.43e-03 | 156 | 155 | 5 | DOID:10283 (is_marker_for) | |
| Disease | Neurodevelopmental Disorders | 1.49e-03 | 93 | 155 | 4 | C1535926 | |
| Disease | Malignant neoplasm of breast | MYH1 HK3 B4GAT1 TCP1 ITGA9 WNK1 BTN3A2 ZEB2 KMT2D GOLIM4 SMARCD1 MACF1 ANAPC5 VPS13B | 1.64e-03 | 1074 | 155 | 14 | C0006142 |
| Disease | anti-Epstein Barr virus antibody measurement | 1.75e-03 | 12 | 155 | 2 | EFO_0009273 | |
| Disease | Fetal Alcohol Spectrum Disorders | 2.06e-03 | 13 | 155 | 2 | C2985290 | |
| Disease | Parkinson's disease symptom measurement | 2.07e-03 | 48 | 155 | 3 | EFO_0600011 | |
| Disease | myopathy (implicated_via_orthology) | 2.07e-03 | 48 | 155 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | forced expiratory volume, response to bronchodilator | 2.52e-03 | 445 | 155 | 8 | EFO_0004314, GO_0097366 | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 2.75e-03 | 15 | 155 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | pemphigus vulgaris | 3.13e-03 | 16 | 155 | 2 | EFO_0004719 | |
| Disease | fourth ventricle volume measurement | 3.13e-03 | 16 | 155 | 2 | EFO_0010303 | |
| Disease | level of Phosphatidylcholine (18:0_20:3) in blood serum | 3.13e-03 | 16 | 155 | 2 | OBA_2045093 | |
| Disease | Familial Progressive Myoclonic Epilepsy | 3.54e-03 | 17 | 155 | 2 | C0751777 | |
| Disease | Atypical Inclusion-Body Disease | 3.54e-03 | 17 | 155 | 2 | C0751776 | |
| Disease | Myoclonic Epilepsies, Progressive | 3.54e-03 | 17 | 155 | 2 | C0751778 | |
| Disease | Biotin-Responsive Encephalopathy | 3.54e-03 | 17 | 155 | 2 | C0751780 | |
| Disease | May-White Syndrome | 3.54e-03 | 17 | 155 | 2 | C0751782 | |
| Disease | Dentatorubral-Pallidoluysian Atrophy | 3.54e-03 | 17 | 155 | 2 | C0751781 | |
| Disease | immature platelet measurement | 3.64e-03 | 119 | 155 | 4 | EFO_0803541 | |
| Disease | Action Myoclonus-Renal Failure Syndrome | 3.97e-03 | 18 | 155 | 2 | C0751779 | |
| Disease | SARS-CoV-2 antibody measurement, response to COVID-19 vaccine | 4.29e-03 | 62 | 155 | 3 | EFO_0803360, EFO_0803362 | |
| Disease | level of Sterol ester (27:1/20:3) in blood serum | 4.42e-03 | 19 | 155 | 2 | OBA_2045199 | |
| Disease | energy expenditure measurement | 4.90e-03 | 20 | 155 | 2 | EFO_0008005 | |
| Disease | cortical surface area measurement | SEMA4D VRK2 ANK3 LAMC3 CACHD1 ADGRV1 PSTPIP1 ITIH5 ZNF106 PDGFD RASGEF1B XRN1 MACF1 SOS1 PDZRN4 | 4.93e-03 | 1345 | 155 | 15 | EFO_0010736 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VVLAKSYNEQRIREN | 266 | P17516 | |
| ENYVIKRELAVVRQQ | 411 | Q96CN4 | |
| QRAISAQQVYGEKRD | 56 | Q9H2F5 | |
| VVYFRQEQEEEGQKR | 101 | Q6ZUV0 | |
| AKVQDYRQAQVERLE | 76 | Q6ZTR7 | |
| YRQAQVERLETKVVN | 81 | Q6ZTR7 | |
| QQEVAAAVIQRCYRK | 1546 | Q9Y6Y1 | |
| EVQQTVYREIVKNLG | 371 | Q4G0S4 | |
| RRASEARGKIVVYNQ | 161 | Q9Y646 | |
| NNVYTIAKRNVEGQD | 871 | P63010 | |
| SLRQVVNVYADGKEV | 71 | O00478 | |
| LSEYVRNQQTIGARK | 241 | Q7L1Q6 | |
| SLRQVVNVYADGKEV | 71 | O00481 | |
| AQQETQKAALRYERA | 126 | Q7L8J4 | |
| NKNELVQLYQVGEVR | 271 | O43505 | |
| VVLAKSYNEQRIRQN | 266 | P42330 | |
| QIGVENTEENRRLYR | 46 | P09972 | |
| QVDKEQFERVLGYIQ | 361 | P30837 | |
| YELQGAREQQKIRQE | 241 | Q14254 | |
| DRVNVENQVLKSGYT | 746 | Q8WXG9 | |
| DVVNRNKQVVEASYT | 101 | Q5VU97 | |
| YERLQRAEAQGKQEV | 766 | Q9UDT6 | |
| RVQGDNKFEVVTTQR | 536 | Q8WZ64 | |
| YGIAQRQRQEEVQEV | 221 | Q5TEZ5 | |
| GNDVINRVYEANVEK | 471 | Q15057 | |
| KGQQADLARYSVTQV | 326 | Q9HBB8 | |
| NVRTIGAQVYEQVLR | 56 | O43286 | |
| SNLKQRQVVRGYAEQ | 216 | Q9P241 | |
| QIVINRDDVQGYAAK | 466 | O94973 | |
| EYVQNFKRQEAEGTR | 41 | P49418 | |
| LQGEVQLTARRYQEK | 181 | Q6ZMN7 | |
| IQRDIEYFVNQRKTG | 261 | Q9H939 | |
| RENVGIYNLSKGVNR | 611 | P69849 | |
| QYQKALRQSAGAVVI | 96 | Q969V3 | |
| QLREQYDEKRSQANG | 141 | O95453 | |
| IEGVYRKAVVLQAQN | 541 | Q9UJX4 | |
| NSVIYGVRTKQIRAQ | 286 | Q8NGJ3 | |
| RAQAEERYGKELVQI | 46 | O43586 | |
| EQLKQERISRYQGVN | 281 | Q13310 | |
| RENVGIYNLSKGVNR | 611 | Q5JPE7 | |
| TISGRKDQVEYLVQQ | 396 | O00505 | |
| RARIYEVEQQIKQRG | 421 | Q86YW9 | |
| RYDVNREQSIGDIQV | 261 | Q86UX2 | |
| EGNAYIDLRVVKQTV | 361 | A6NDA9 | |
| QELVERYSQKAARNG | 426 | P51654 | |
| AGEEEALRQYQQRKQ | 241 | Q9BYM8 | |
| RTDNNKNLAQRVVVY | 36 | Q5W064 | |
| EVQRVVGALASQDYR | 336 | P0C7T5 | |
| NVRQSLGNSQREYEK | 21 | Q658Y4 | |
| EGREERIYNQSQSNK | 591 | Q8IYD8 | |
| YQDGIRAAKRNIQIE | 1706 | Q15751 | |
| GQDQFVRIYDQRKID | 386 | P0C7V8 | |
| RRDETIQVKGNGYVQ | 51 | Q9GZP0 | |
| RQITANEVYGKQISA | 2756 | Q9Y6V0 | |
| QEKRGAVYERVTTIN | 381 | Q9BZD4 | |
| EQEELYVRVQNGFRK | 1471 | P39060 | |
| YVRVQNGFRKVQLEA | 1476 | P39060 | |
| RENVGIYNLSKGVNR | 611 | Q15155 | |
| QYSEGVQREAQRIAL | 291 | Q8IZD2 | |
| NEQYKLVSDTIGQRV | 1776 | O94854 | |
| KTVIEQVYANGIRNI | 786 | O60337 | |
| ENRRTYQNLVIEKDG | 131 | P50748 | |
| LRKYAEERNGVNVVS | 781 | P22413 | |
| NAEVVTAYRGKKRQE | 136 | P12882 | |
| GVFEQNQDRKHRTYV | 81 | Q96G61 | |
| VGQIRKAYDTRVSQD | 491 | O15553 | |
| QIAEINSQVRRYLEG | 391 | Q9HAQ2 | |
| LYAGRAQKRVERQNE | 261 | Q4VXU2 | |
| IASGEEQTYRKNVQQ | 141 | Q0VAM2 | |
| IRRQGAYNIDVVAVV | 206 | P52790 | |
| REYTAAVEAKQVAQQ | 191 | Q99623 | |
| KRESVIQQRVYEGNA | 356 | Q9GZU2 | |
| RQIEAGYKQEVEQLR | 1026 | Q9NYA4 | |
| GYKQEVEQLRRQVRE | 1031 | Q9NYA4 | |
| EGRVRVNSAYQDKVS | 91 | P16112 | |
| QGYNTAREKPTREVQ | 266 | O00461 | |
| REQANKRNGYEIGTI | 196 | Q96HP4 | |
| IRDEGQVTVYINRGN | 331 | Q13797 | |
| YRKNNISVFEVDGNV | 571 | Q92794 | |
| TVYQEARKIVGAELQ | 996 | A1KZ92 | |
| QDKIYVGEDARNVTV | 1341 | A1KZ92 | |
| EQINNYVEKRTGRKV | 181 | P20848 | |
| QQIVRAAQDYLQEKR | 1666 | Q9P2D3 | |
| KTEIENVRNGTQVRY | 221 | P48547 | |
| TYRVAVGKNNLEVED | 81 | Q99895 | |
| NKRLITADQREYQQE | 2031 | Q8NF50 | |
| GRYTSQDQQAAQRVK | 116 | Q9UG22 | |
| SELNKQYQIVERVIA | 371 | O14647 | |
| RVPSEVQQRYANVEK | 221 | A8MYV0 | |
| YVNTTGVQEERKNRT | 196 | Q8WU20 | |
| DTYVTKNLRREGQIQ | 101 | P57058 | |
| VTVAAGLDREKVQQY | 341 | P55283 | |
| GLDREKVQQYTVIVQ | 346 | P55283 | |
| VVRYLVQDGAQVEAK | 481 | Q12955 | |
| SLRQVVNVYADGKEV | 71 | P78410 | |
| QTNAGYLEQVKRQRG | 56 | Q05932 | |
| RENREQYQVVIQAKD | 226 | P55285 | |
| SQGTRYQTRQAVKAV | 856 | Q9ULU4 | |
| RENREQYQVVIQAKD | 226 | Q9ULB4 | |
| DVGNREEVYQTAKAV | 96 | O75911 | |
| IQEGIYVAIQRSDKR | 26 | Q8N4N8 | |
| AVDRVYRIGQKENVV | 566 | Q2NKX8 | |
| YIERVQREKANGTTV | 81 | Q9UNX3 | |
| RAIKYRQENQEAVGG | 206 | Q9BPW8 | |
| NHEQSYVGKRSNRVV | 161 | Q9Y5Y5 | |
| YVGKRSNRVVRTLQN | 166 | Q9Y5Y5 | |
| VRGTQRAVGVQNYLE | 31 | Q8N0Z8 | |
| YVSKEQRLQAVQAAI | 761 | Q9Y3M8 | |
| SAQQELKQRQRAEIY | 26 | Q8N300 | |
| GYEEQQIQEKVATFR | 81 | Q9UQ35 | |
| VVRYLADQNNQVRKT | 136 | Q8TF05 | |
| YSKVQQRRQELEQAL | 496 | Q96GM5 | |
| VQYRGRVRVQLKQED | 76 | P09132 | |
| EERQNIYKEVIAVQG | 876 | O43426 | |
| YVNTEGRAQQTKVAV | 596 | P28331 | |
| ERLKANQVATGIRYN | 186 | Q9Y6U3 | |
| AINQAIANEYEVRRK | 206 | Q8NCA5 | |
| TLVDNIQRYVEDGKN | 1291 | Q8TCU6 | |
| RRQNQDRINKTVLYG | 791 | Q9H156 | |
| RVRNEITSNYKQQTG | 1161 | Q149N8 | |
| KEAVRYINENLIVNT | 126 | P17987 | |
| EQAIREQRLYKQERG | 106 | Q86WV5 | |
| KDVNYTQIVVDRTQA | 416 | Q92854 | |
| RRKVAEITGEIQQYQ | 961 | Q07889 | |
| VVQTRQQAYRDKLAQ | 91 | Q9BZK7 | |
| RYEKERQLNEAVGNV | 826 | O75969 | |
| VVLAKSYNEQRIRQN | 266 | Q04828 | |
| VVLAKSYNEQRIRQN | 266 | P52895 | |
| QEDIQKGDVSSVRYR | 1201 | A4UGR9 | |
| QTYIVGRAVRKLQAQ | 1141 | O00562 | |
| SDVAEKLYIQQIVQR | 2586 | Q63HN8 | |
| KYNAAVQVEVVRASR | 231 | P56706 | |
| ENQAVQTARLVQYRG | 46 | P55916 | |
| RQNTAGRRKVQVSYV | 6 | Q8TAF3 | |
| IRDEVEKYNRNGVNA | 21 | Q8TAF3 | |
| ELKAAYDQRQRQGEN | 1031 | Q9UBZ9 | |
| RLSQLEGVNVERYKQ | 226 | Q96QK1 | |
| YIERVQREKANGTTV | 81 | P61254 | |
| IGSKTDAERVVNQYQ | 396 | Q8NEM7 | |
| LTGRKYQINQNGEVR | 801 | Q8IZH2 | |
| VEVQVKYRTAALSNQ | 21 | B1AK76 | |
| VRQLQEGAAQLRTVY | 1891 | Q9H254 | |
| VRKINDQYIAVQGAE | 556 | Q9H0V1 | |
| DRYQGNQDRVLRQVT | 126 | Q2M218 | |
| DKYGQNESFARIQVR | 101 | P33981 | |
| VDGVRERLSEQQYNR | 3941 | Q7Z7G8 | |
| RVVAQYAQRNAKGGV | 1201 | Q6PGP7 | |
| ERVIKTQYQSAQRAE | 486 | Q9WJR5 | |
| TQYSGKQRTENVLRI | 651 | Q13395 | |
| QDRVLVRKYQGVTQG | 556 | Q9H7D7 | |
| QNAAQIYRRVTSGVK | 426 | Q9H4A3 | |
| GNATVKQSRYRIIIQ | 756 | Q9C0I4 | |
| KQSRYRIIIQEAANG | 761 | Q9C0I4 | |
| RRKNVVNYDNVVDTG | 21 | O60315 | |
| IEQTKRVYDQVGTQE | 41 | P52888 | |
| QERYIQAEREKGILQ | 481 | Q96QC0 | |
| QRYSQQLRKVQEGAQ | 216 | Q9BVG3 | |
| QRQENDKLGTVATYR | 281 | Q9H2Y7 | |
| EAAQESTRRRQKYQE | 391 | Q86Y07 | |
| ANRREKIYEEQNRGI | 5436 | O14686 | |
| YQEVQAAQKALRTAV | 1211 | Q9Y6N6 | |
| LIEKSRVVYQNEGER | 186 | Q8N1T3 | |
| IQQYFRGQQTVRKAI | 786 | Q9NQX4 | |
| KQTYIRRVGEAVNLV | 846 | Q00872 | |
| VVQEDRGRYQVITNG | 411 | Q14324 | |
| VVYGVVRRSDQNQQK | 71 | P0CAP1 | |
| QRVKRNQENISSVLY | 6326 | P20929 |